cpii_10q-2qfy08.htm


UNITED STATES
SECURITIES AND EXCHANGE
 COMMISSION
Washington, DC 20549
 
FORM 10-Q
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 28, 2008
 
 or
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ________ to ________
 
 
Commission file number: 00051928
 
 
CPI INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
75-3142681
(I.R.S. Employer Identification No.)
811 Hansen Way, Palo Alto, California 94303
(Address of Principal Executive Offices and Zip Code)
(650) 846-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
 
Yes  x  No  ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer     ¨                                                         Accelerated filer        x  
Non-accelerated filer       ¨ (Do not check if a smaller reporting company)      Smaller reporting company  ¨ 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes¨  No  x
 
 
APPLICABLE ONLY TO CORPORATE ISSUERS:
 
Indicate the number of shares outstanding for each of the registrant’s classes of Common Stock, as of the latest practicable date: 16,511,405 shares of Common Stock, $0.01 par value, at April 28, 2008.
 

 
 



 
CPI INTERNATIONAL, INC.
and Subsidiaries

10-Q REPORT
 
INDEX
 
 
4
         
 
4
     
4
     
5
     
6
     
7
 
37
 
58
 
60
         
61
         
 
61
 
61
 
61
 
61
 
61
 
61
 
62
 
 
2

 
CPI INTERNATIONAL, INC.
and Subsidiaries

Cautionary Statements Regarding Forward-Looking Statements
 
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that relate to future events or our future financial performance. In some cases, readers can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.
 
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, which could cause actual results to differ materially from the results projected, expected or implied by the forward-looking statements. These risk factors include, without limitation, competition in our end markets; our significant amount of debt; changes or reductions in the U.S. defense budget; currency fluctuations; U.S. Government contracts laws and regulations; changes in technology; the impact of unexpected costs; and inability to obtain raw materials and components. All written and oral forward-looking statements made in connection with this report that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing risk factors and other cautionary statements included herein and in our other filings with the Securities and Exchange Commission (“SEC”). We are under no duty to update any of the forward-looking statements after the date of this report to conform such statements to actual results or to changes in our expectations.
 
The information in this report is not a complete description of our business or the risks and uncertainties associated with an investment in our securities. You should carefully consider the various risks and uncertainties that impact our business and the other information in this report and in our other filings with the SEC before you decide to invest in our securities or to maintain or increase your investment.
 
 
 
3

 
CPI INTERNATIONAL, INC.
and Subsidiaries

Part I:  FINANCIAL INFORMATION
 
 
Item 1.        Unaudited Condensed Consolidated Financial Statements
 
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data – unaudited)
 
   
March 28,
   
September 28,
 
   
2008
   
2007
 
Assets
           
Current Assets:
           
Cash and cash equivalents
  $ 20,241     $ 20,474  
Restricted cash
    1,790       2,255  
Accounts receivable, net
    50,719       52,589  
Inventories
    66,861       67,447  
Deferred tax assets
    9,948       9,744  
Prepaid and other current assets
    3,787       4,639  
Total current assets
    153,346       157,148  
Property, plant, and equipment, net
    64,819       66,048  
Deferred debt issue costs, net
    5,728       6,533  
Intangible assets, net
    80,201       81,743  
Goodwill
    162,535       161,573  
Other long-term assets
    796       3,177  
Total assets
  $ 467,425     $ 476,222  
                 
Liabilities and stockholders’ equity
               
Current Liabilities:
               
Current portion of long-term debt
  $ 2,000     $ 1,000  
Accounts payable
    21,849       21,794  
Accrued expenses
    26,045       26,349  
Product warranty
    4,952       5,578  
Income taxes payable
    5,100       8,748  
Advance payments from customers
    11,655       12,132  
Total current liabilities
    71,601       75,601  
Deferred income taxes
    26,310       28,394  
Long-term debt, less current portion
    234,623       245,567  
Other long-term liabilities
    2,120       754  
Total liabilities
    334,654       350,316  
Commitments and contingencies
               
Stockholders’ equity
               
Common stock ($0.01 par value, 90,000 shares authorized; 16,485 and 16,370 shares issued and outstanding)
      165        164   
Additional paid-in capital
    70,165       68,763  
Accumulated other comprehensive (loss) income
    (2,265 )     937  
Retained earnings
    64,706       56,042  
Total stockholders’ equity
    132,771       125,906  
Total liabilities and stockholders' equity
  $ 467,425     $ 476,222  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 

 
4

 
CPI INTERNATIONAL, INC.
and Subsidiaries


 
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(In thousands, except per share data – unaudited)
 
 
   
Three Months Ended
   
Six Months Ended
 
   
March 28,
2008
   
March 30,
2007
   
March 28,
2008
   
March 30,
2007
 
 Sales
  $ 94,804     $ 88,444     $ 180,714     $ 172,167  
 Cost of sales
    66,738       60,739       128,512       117,881  
 Gross profit
    28,066       27,705       52,202       54,286  
 Operating costs and expenses:
                               
 Research and development
    2,930       2,352       5,654       4,243  
 Selling and marketing
    5,328       4,799       10,500       9,628  
 General and administrative
    5,492       5,846       11,645       10,250  
 Amortization of acquisition-related intangible assets
    781       546       1,562       1,094  
 Net loss on disposition of fixed assets
    41       40       75       58  
 Total operating costs and expenses
    14,572       13,583       29,436       25,273  
 Operating income
    13,494       14,122       22,766       29,013  
 Interest expense, net
    4,805       5,275       9,617       10,614  
 Loss on debt extinguishment
    393       -       393       -  
 Income before income taxes
    8,296       8,847       12,756       18,399  
 Income tax expense
    2,142       3,087       4,092       6,804  
 Net income
  $ 6,154     $ 5,760     $ 8,664     $ 11,595  
                                 
 Other comprehensive income, net of tax
                               
Net unrealized loss on cash flow hedges
    (2,001 )     (17 )     (3,202 )     (406 )
Comprehensive income
  $ 4,153     $ 5,743     $ 5,462     $ 11,189  
                                 
 Earnings per share - Basic
  $ 0.38     $ 0.35     $ 0.53     $ 0.72  
 Earnings per share - Diluted
  $ 0.35     $ 0.32     $ 0.49     $ 0.66  
                                 
 Shares used to compute earnings per share - Basic
    16,387       16,253       16,379       16,161  
 Shares used to compute earnings per share - Diluted
    17,656       17,730       17,744       17,646  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
5

 
CPI INTERNATIONAL, INC.
and Subsidiaries

 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (In thousands – unaudited)
 
   
Six Months Ended
 
   
March 28,
   
March 30,
 
   
2008
   
2007
 
Cash flows from operating activities
           
Net cash provided by operating activities
  $ 10,439     $ 6,299  
                 
Cash flows from investing activities
               
Capital expenditures
    (2,558 )     (5,347 )
Proceeds from adjustment to acquisition purchase price
    1,615       -  
Capitalized expenses relating to potential business acquisition
    -       (119 )
Payment of patent application fees
    (147 )     -  
Net cash used in investing activities
    (1,090 )     (5,466 )
                 
Cash flows from financing activities
               
Repayments of debt
    (10,000 )     (5,000 )
Proceeds from issuance of common stock to employees
    418       398  
Proceeds from exercise of stock options
    -       542  
Excess tax benefit on stock option exercises
    -       679  
Net cash used in financing activities
    (9,582 )     (3,381 )
                 
Net decrease in cash and cash equivalents
    (233 )     (2,548 )
Cash and cash equivalents at beginning of period
    20,474       30,153  
Cash and cash equivalents at end of period
  $ 20,241     $ 27,605  
                 
Supplemental cash flow disclosures
               
Cash paid for interest
  $ 8,293     $ 10,707  
Cash paid for income taxes, net of refunds
  $ 8,722     $ 10,495  


The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
6

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(All tabular dollar amounts in thousands except share and per share amounts)
 
 
1.  
The Company and a Summary of its Significant Accounting Policies
 
The Company
 
Unless the context otherwise requires, “CPI International” means CPI International, Inc., and “CPI” means Communications & Power Industries, Inc. CPI is a direct subsidiary of CPI International.  CPI International is a holding company with no operations of its own.  The term the “Company” refers to CPI International and its direct and indirect subsidiaries on a consolidated basis.
 
The accompanying consolidated financial statements represent the consolidated results and financial position of CPI International, which is controlled by affiliates of The Cypress Group L.L.C. (“Cypress”).  CPI International, through its wholly owned subsidiary, CPI, develops, manufactures, and distributes microwave and power grid Vacuum Electron Devices (“VEDs”), microwave amplifiers, modulators and various other power supply equipment and devices.  The Company has two reportable segments, VED and satcom equipment.
 
Basis of Presentation and Consolidation
 
The Company’s fiscal year is the 52- or 53-week period that ends on the Friday nearest September 30. Fiscal year 2008 comprises the 53-week period ending October 3, 2008 and fiscal year 2007 comprised the 52-week period ending September 28, 2007. The second quarters of fiscal years 2008 and 2007 both include 13 weeks. The first two quarters of fiscal years 2008 and 2007 both include 26 weeks. All period references are to the Company’s fiscal periods unless otherwise indicated.

The accompanying unaudited condensed consolidated financial statements of the Company as of March 28, 2008 and for the three and six months ended March 28, 2008 are unaudited and reflect all normal recurring adjustments which are, in the opinion of management, necessary for the fair statement of such financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2007.  The condensed consolidated balance sheet as of September 28, 2007 has been derived from the audited financial statements at that date. The results of operations for the interim period ended March 28, 2008 are not necessarily indicative of results to be expected for the full year.
 
The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant intercompany balances, transactions, and stockholdings have been eliminated in consolidation. 

Use of Estimates and Assumptions
 
 The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of sales and costs and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to provision for revenue recognition; inventory and inventory reserves; product warranty; business combinations; recoverability and valuation of recorded amounts of long-lived assets and identifiable intangible assets, including goodwill; recognition of share-based compensation; and recognition and

 
7

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)



measurement of current and deferred income tax assets and liabilities. The Company bases its estimates on various factors and information, which may include, but are not limited to, history and prior experience, experience of other enterprises in the same industry, new related events, current economic conditions and information from third party professionals that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

Revenue Recognition
 
Sales are recognized when persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured. The Company’s products are generally subject to warranties, and the Company provides for the estimated future costs of repair, replacement or customer accommodation in cost of sales.
 
The Company has commercial and U.S. Government fixed-price contracts that are accounted for under American Institute of Certified Public Accountants Statement of Position No. 81-1, “Accounting for Performance of Construction-Type and Certain Production-Type Contracts.” These contracts are generally longer than one year in duration and include a material amount of product development. The Company uses the percentage-of-completion method when reasonably dependable estimates of the extent of progress toward completion, contract revenues and contract costs can be made. The portion of revenue earned or the amount of gross profit earned for a period is determined by measuring the extent of progress toward completion using total cost incurred to date and estimated costs at contract completion.
 
 
2.  
Recently Issued Accounting Standards
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation (“FIN”) No. 48, “Accounting for Income Tax Uncertainties.” FIN No. 48 defines the threshold for recognizing the benefits of tax return positions in the financial statements as “more-likely-than-not” to be sustained by the taxing authority. The recently issued literature also provides guidance on the derecognition, measurement and classification of income tax uncertainties, along with any related interest and penalties. FIN No. 48 also includes guidance concerning accounting for income tax uncertainties in interim periods and increases the level of disclosures associated with any recorded income tax uncertainties. Effective in the first quarter of fiscal year 2008 starting September 29, 2007, the Company adopted FIN No. 48. The adoption of FIN No. 48 did not have any impact on the Company’s financial position, net income or prior year financial statements. See Note 9, "Income Taxes," for further discussion.

In September 2006, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value under other accounting pronouncements that permit or require fair value measurements, changes the methods used to measure fair value and expands disclosures about fair value measurements. In particular, disclosures are required to provide information on: the extent to which fair value is used to measure assets and liabilities; the inputs used to develop measurements; and the effect of certain of the measurements on earnings (or changes in net assets). SFAS No. 157 is effective for fiscal years beginning after November 15, 2007 for financial assets and liabilities and for fiscal years beginning after November 15, 2008 for non-financial assets and liabilities. Early adoption, as of the beginning of an entity’s fiscal year, is also

 
8

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

permitted, provided interim financial statements have not yet been issued. The Company will be required to adopt SFAS No. 157 in its fiscal year 2009 commencing October 4, 2008 for financial assets and liabilities and in its fiscal year 2010 commencing October 2, 2009 for non-financial assets and liabilities. The Company is currently evaluating the potential impact, if any, that the adoption of this new standard will have on its consolidated financial statements.
 
        In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB Statement No. 115.” SFAS No. 159 permits companies to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. The objective of SFAS No. 159 is to provide opportunities to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply hedge accounting provisions. SFAS No. 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The Company will be required to adopt SFAS No. 159 in its fiscal year 2009 commencing October 4, 2008 and is currently evaluating the impact, if any, that the adoption of this new standard will have on its consolidated financial statements.
 
        In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statement—amendments of ARB No. 51.” SFAS No. 160 states that accounting and reporting for minority interests will be recharacterized as noncontrolling interests and classified as a component of equity. SFAS No. 160 also establishes reporting requirements that provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS No. 160 applies to all entities that prepare consolidated financial statements, except not-for-profit organizations, but will affect only those entities that have an outstanding noncontrolling interest in one or more subsidiaries or that deconsolidate a subsidiary. SFAS No. 160 is effective for fiscal years beginning after December 15, 2008. The Company will be required to adopt SFAS No. 160 in its fiscal year 2010 commencing October 3, 2009 and is currently evaluating the impact, if any, that the adoption of this new standard will have on its consolidated financial statements.
    
    In December 2007, the FASB issued SFAS No. 141 (revised 2007) (“SFAS No. 141(R)”), “Business Combinations,” which replaces SFAS No. 141. SFAS No. 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any non controlling interest in the acquiree and the goodwill acquired. The Statement also establishes disclosure requirements which will enable users to evaluate the nature and financial effects of the business combination. SFAS No. 141(R) is effective for fiscal years beginning after December 15, 2008. The Company will be required to adopt SFAS No. 141(R) in its fiscal year 2010 commencing October 3, 2009 and is currently evaluating the impact, if any, that the adoption of this new standard will have on its consolidated financial statements.
 
    In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133.” SFAS No. 161 requires enhanced disclosures about an entity’s derivative instruments and hedging activities including: (1) how and why an entity uses derivative instruments; (2) how derivative instruments and related hedged items are accounted for under SFAS No. 133 and its related interpretations; and (3) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15,
 
 
9

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

2008, with earlier application encouraged. The Company will be required to adopt SFAS No. 161 in its second quarter of fiscal year 2009 commencing January 3, 2009 and is currently evaluating the impact, if any, that the adoption of this new standard will have on its consolidated financial statements.
 
 
3.  
Supplemental Balance Sheet Information
 
 
Accounts Receivable:  Accounts receivable are stated net of allowances for doubtful accounts as follows:
 
 
 
March 28,
   
 September 28,
   
2008
   
 2007
 
Accounts receivable
  $ 51,108     $ 52,678  
Less: Allowance for doubtful accounts
    (389 )     (89 )
Accounts receivable, net
  $ 50,719     $ 52,589  

Inventories:    The following table provides details of inventories, net of reserves:
 
   
March 28,
   
 September 28,
   
2008
   
 2007
 
Raw material and parts
  $ 40,355     $ 40,725  
Work in process
    19,768       18,168  
Finished goods
    6,738       8,554  
    $ 66,861     $ 67,447  

Reserve for excess, slow moving and obsolete inventory:    The following table summarizes the activity related to reserves for excess, slow moving and obsolete inventory:
 
   
Six Months Ended
 
   
March 28,
   
March 30,
 
   
2008
   
2007
 
Balance at beginning of fiscal year
  $ 9,784     $ 8,822  
Inventory provision, charged to cost of sales
    550       540  
Inventory write-offs
    (397 )     (218 )
Balance at end of period
  $ 9,937     $ 9,144  
 
 
10

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
Reserve for loss contracts:   The following table summarizes the activity related to reserves for loss contracts:
 
   
Six Months Ended
 
   
March 28,
   
March 30,
 
   
2008
   
2007
 
Balance at beginning of fiscal year
  $ 2,700     $ 1,702  
Provision for loss contracts, charged to
               
cost of sales
    1,431       629  
Reduction upon revenue
               
recognition
    (2,096 )     (1,033 )
Balance at end of period
  $ 2,035     $ 1,298  
 
 
Reserve for loss contracts are reported in the condensed consolidated balance sheet in the following accounts:
 
   
March 28,
   
March 30,
 
   
2008
   
2007
 
Inventories
  $ 953     $ 971  
Accrued expenses
    1,082       327  
    $ 2,035     $ 1,298  

Intangible Assets: The following tables present the details of the Company’s total acquisition-related intangible assets:
 
   
Weighted Average Useful Life
(in years)
   
March 28, 2008
   
September 28, 2007
 
       
Cost
   
Accumulated Amortization
   
Net
   
Cost
   
Accumulated Amortization
   
Net
 
VED Core Technology
 
 50
      $ 30,700     $ (2,580 )   $ 28,120     $ 30,700     $ (2,273 )   $ 28,427  
VED Application Technology
 
 25
        19,800       (3,317 )     16,483       19,800       (2,921 )     16,879  
X-ray Generator and Satcom
                                                       
Application Technology
 
 15
        8,000       (2,241 )     5,759       8,000       (1,974 )     6,026  
Antenna and Telemetry
                                                       
Technology
 
 25
        5,300       (135 )     5,165       5,300       (29 )     5,271  
Customer backlog
 
 1
        580       (368 )     212       580       (78 )     502  
Land lease
 
 46
        11,810       (1,054 )     10,756       11,810       (928 )     10,882  
Tradename
 
Indefinite
      7,600       -       7,600       7,600       -       7,600  
Customer list and programs
 
 25
        6,280       (817 )     5,463       6,280       (684 )     5,596  
Noncompete agreement
 
 5
        640       (144 )     496       640       (80 )     560  
Patent application fees
 
 -
        147       -       147       -       -       -  
            $ 90,857     $ (10,656 )   $ 80,201     $ 90,710     $ (8,967 )   $ 81,743  
 
 
11

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Intangible assets, net as of March 28, 2008 include a total of approximately $0.1 million of application costs and associated legal costs incurred to obtain certain patents. Upon obtaining these patents, they will be amortized on a straight-line basis and charged to operations over their estimated useful lives, not to exceed 17 years.
 
The amortization of intangible assets amounted to $0.8 million and $1.7 million for the three and six months ended March 28, 2008, respectively, and $0.6 million and $1.2 million for the corresponding periods of fiscal year 2007.
 
The estimated future amortization expense of intangible assets, excluding the Company’s unamortized tradenames, is as follows:
 
Fiscal Year
 
Amount
 
2008 (remaining six months)
  $ 1,615  
2009
    2,808  
2010
    2,786  
2011
    2,786  
2012
    2,772  
Thereafter
    59,834  
    $ 72,601  

Goodwill:    The following table sets forth the changes in goodwill by reportable segment:
 
   
Reportable Segments
 
   
VED
   
Satcom
   
Other
   
Total
 
Balance at September 28, 2007
  $ 132,897     $ 13,830     $ 14,846     $ 161,573  
Malibu purchase price adjustment
    -       -       1,009       1,009  
Other
    -       -       (47 )     (47 )
Balance at March 28, 2008
  $ 132,897     $ 13,830     $ 15,808     $ 162,535  
 
    During the three months ended March 28, 2008, the Company finalized the purchase price for Malibu Research Associates, Inc., resulting in a $1.0 million increase in goodwill. See Note 4 for details. Other represents tax benefit from amortization expense for the excess of tax goodwill over the book goodwill.
 
 
Product Warranty:    The following table summarizes the activity related to product warranty:
 
   
Six Months Ended
 
   
March 28,
   
March 30,
 
   
2008
   
2007
 
Balance at beginning of fiscal year
  $ 5,578     $ 5,958  
Estimates for product warranty, charged to cost of sales
    1,406       2,374  
Actual costs of warranty claims
    (2,032 )     (2,807 )
Balance at end of period
  $ 4,952     $ 5,525  

 
12

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

4.           Acquisition
 
Malibu Research Associates
 
On August 10, 2007, the Company completed its acquisition of all outstanding common stock of the privately held Malibu Research Associates, Inc. (“Malibu”). Malibu, headquartered in Camarillo, California, is a designer, manufacturer and integrator of advanced antenna systems for radar, radar simulators and telemetry systems, as well as for data links used in ground, airborne, unmanned aerial vehicles (“UAV”) and shipboard systems. Under the terms of the purchase agreement, at the closing of the acquisition, the Company paid cash of approximately $22.4 million, which included $2.3 million and $1.0 million placed into indemnity and working capital escrow accounts, respectively. The indemnity escrow amount was provided to ensure funds are available to satisfy potential indemnification claims asserted prior to January 1, 2009, and the working capital escrow amount was provided to satisfy any negative differences between the estimated working capital amount as of the acquisition closing date and the actual working capital amount at the acquisition closing date.
 
For financial reporting purposes, consideration of approximately $2.6 million, which was part of the cash consideration paid for Malibu at the closing of the acquisition, was excluded from the purchase price allocation and was reported as other long-term assets in the consolidated balance sheet at September 28, 2007.  This consideration amount represents the difference between the estimated working capital amount as of the acquisition closing date and the actual working capital amount as of the acquisition closing date. In accordance with SFAS No. 141, any contingent consideration that has not been determined beyond a reasonable doubt is excluded from the purchase price allocation until the contingency is resolved. The Company intended to make a claim against the working capital escrow account of $1.0 million and, if necessary, the indemnity escrow account of $2.3 million to recover the working capital shortfall once the amount of such shortfall had been finally determined.
 
    During the second quarter of fiscal year 2008, the valuation of Malibu’s net working capital amount as of the acquisition closing date was finalized, resulting in a disbursement of cash to the Company of $1.6 million from the escrow accounts. The remaining $1.0 million of consideration was allocated to goodwill as the working capital contingency was resolved, which resulted in an adjusted cash purchase price of $20.7 million.

Additionally, the Company may be required to pay a potential earnout to the former stockholders of Malibu of up to $14.0 million, which is primarily contingent upon the achievement of certain financial objectives over the three years following the acquisition; and a discretionary earnout of up to $1.0 million contingent upon achievement of certain succession planning goals by June 30, 2010. As of March 28, 2008, the Company has not accrued any of these contingent earnout amounts as achievement of the objectives and goals has not occurred. Any earnout consideration paid based on financial performance will be recorded as additional goodwill. Any discretionary succession earnout consideration paid will be recorded as general and administrative expense.
 
Under the purchase method of accounting, the assets and liabilities of Malibu were adjusted to their fair values and the excess of the purchase price over the fair value of the net assets acquired was recorded as goodwill. The allocation of the purchase price to specific assets and liabilities was based, in part, upon internal estimates of cash flow and recoverability. The valuation of identifiable intangible
 
 
13

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
assets acquired was based on management’s estimates, currently available information and reasonable and supportable assumptions. This purchase price allocation was generally based on the fair value of these assets determined using the income approach.
 
The following table summarizes the allocation of the fair value of Malibu’s assets acquired and liabilities assumed:
 
Net current liabilities
  $ (3,938 )
Property, plant and equipment
    719  
Deferred tax liabilities
    (703 )
Identifiable intangible assets
    8,790  
Goodwill
    15,865  
    $ 20,733  
 
 
The following table presents details of the purchased intangible assets acquired:
 
   
Weighted Average Useful Life
(in years)
   
Amount
 
Non compete agreements
 
 5
      $ 530  
Tradename
 
Indefinite
 
      1,800  
Antenna and Telemetry technology
 
 25
        5,300  
Backlog
 
 1
        580  
Customer relationships
 
 15
        580  
            $ 8,790  

In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” goodwill and indefinite lived intangibles will not be amortized but will be tested for impairment at least annually.
 
The Company’s consolidated financial statements include Malibu’s financial results from the acquisition date.
 
Pro Forma Results
 
        Pro forma information giving effect to the Malibu acquisition has not been presented because the pro forma information would not differ materially from the historical results of the Company.
 
 
14

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
5.           Long-Term Debt
 
Long-term debt comprises the following:
 
   
March 28,
   
  September 28,
   
2008
   
  2007
 
Term loan, expiring 2014
  $ 95,750     $ 99,750  
8% Senior subordinated notes due 2012
    125,000       125,000  
Floating rate senior notes due 2015, net of issue discount of $127 and $183
    15,873       21,817  
      236,623       246,567  
Less:  Current portion
    2,000       1,000  
Long-term portion
  $ 234,623     $ 245,567  
                 
Standby letters of credit
  $ 5,882     $ 3,725  

Senior Credit Facilities: On August 1, 2007, CPI amended and restated its then existing senior credit facilities. The amended and restated senior credit facilities (the “Senior Credit Facilities”) provide for borrowings of up to an aggregate principal amount of $160 million, consisting of a $100 million term loan facility (“Term Loan”) and a $60 million revolving credit facility (“Revolver”), with a sub-facility of $15 million for letters of credit and $5 million for swing line loans. Upon certain specified conditions, including maintaining a senior secured leverage ratio of 3.75:1 or less on a pro forma basis, CPI may seek commitments for a new class of term loans, not to exceed $125 million in the aggregate.  The Senior Credit Facilities are guaranteed by CPI International and all of CPI’s domestic subsidiaries and are secured by substantially all of the assets of CPI International, CPI and CPI’s domestic subsidiaries.
 
Except as provided in the following sentence, the Term Loan will mature on August 1, 2014 and the Revolver will mature on August 1, 2013.  However, if, prior to August 1, 2011, CPI has not repaid or refinanced its $125 million 8% Senior Subordinated Notes due 2012, both the Term Loan and the Revolver will mature on August 1, 2011.
 
The Senior Credit Facilities replaced CPI’s previous senior credit facilities of $130 million. On the closing date of the Senior Credit Facilities, CPI borrowed $100 million under the Term Loan. Borrowings under the Senior Credit Facilities bear interest at a rate equal to, at CPI’s option, LIBOR or the ABR plus the applicable margin. The ABR is the greater of the (a) the prime rate and (b) the federal funds rate plus 0.50%. For Term Loans, the applicable margin will be 2.00% for LIBOR borrowings and 1.00% for ABR borrowings. The applicable margins under the Revolver vary depending on CPI’s leverage ratio, as defined in the Senior Credit Facilities, and range from 1.25% to 2.00% for LIBOR borrowings and from 0.25% to 1.00% for ABR borrowings.
 
In addition to customary fronting and administrative fees under the Senior Credit Facilities, CPI will pay letter of credit participation fees equal to the applicable LIBOR margin per annum on the average daily amount of the letter of credit exposure, and a commitment fee on the average daily unused commitments under the Revolver.  The commitment fee will vary depending on CPI’s leverage ratio, as defined in the Senior Credit Facilities, and will range from 0.25% to 0.50%.
 
 
15

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
The Senior Credit Facilities require that CPI repay $250,000 of the Term Loan at the end of each fiscal quarter prior to the maturity date of the Term Loan, with the remainder due on the maturity date.  CPI is required to prepay its outstanding loans under the Senior Credit Facilities, subject to certain exceptions and limitations, with net cash proceeds received from certain events, including, without limitation (1) all such proceeds received from certain asset sales by CPI International, CPI or any of CPI’s subsidiaries, (2) all such proceeds received from issuances of debt (other than certain specified permitted debt) or preferred stock by CPI International, CPI or any of CPI’s subsidiaries, and (3) all such proceeds paid to CPI International, CPI or any of CPI’s subsidiaries from casualty and condemnation events in excess of amounts applied to replace, restore or reinvest in any properties for which proceeds were paid within a specified period.
 
If CPI’s leverage ratio, as defined in the Senior Credit Facilities, exceeds 3.5:1 at the end of any fiscal year, CPI will also be required to make an annual prepayment within 90 days after the end of such fiscal year equal to 50% of excess cash flow, as defined in the Senior Credit Facilities, less optional prepayments made during the fiscal year.  CPI can make optional prepayments on the outstanding loans at any time without premium or penalty, except for customary “breakage” costs with respect to LIBOR loans.
 
The Senior Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the ability of CPI International, CPI or any of CPI’s subsidiaries to: sell assets; engage in mergers and acquisitions; pay dividends and distributions or repurchase their capital stock; incur additional indebtedness or issue equity interests; make investments and loans; create liens or further negative pledges on assets; engage in certain transactions with affiliates; enter into sale and leaseback transactions; amend agreements or make prepayments relating to subordinated indebtedness; and amend or waive provisions of charter documents in a manner materially adverse to the lenders. CPI and its subsidiaries must comply with a maximum capital expenditure limitation and a maximum total secured leverage ratio, each calculated on a consolidated basis for CPI.
 
CPI made repayments on the Term Loan of $4.0 million during the first six months of fiscal year 2008 and $250,000 during the fourth quarter of fiscal year 2007, leaving a principal balance of $95.75 million as of March 28, 2008. The $4.0 million Term Loan repayment during the first six months of fiscal year 2008 comprised the scheduled amortization payment of $250,000 for each of the first and second quarters of fiscal year 2008 and an optional prepayment of $3.5 million. A portion of the optional prepayment will be applied against the scheduled amortization payments due for the third and fourth quarters of fiscal year 2008 and those due for fiscal years 2009 and 2010.
 
At March 28, 2008, the amount available for borrowing under the Revolver, after taking into account the Company’s outstanding letters of credit of $5.9 million, was approximately $54.1 million.
 
See Note 12 “Subsequent Event” for a discussion of the additional $2.0 million prepayment of the Term Loan made in April 2008.
 
8% Senior Subordinated Notes due 2012 of CPI:  As of March 28, 2008, CPI had $125.0 million in aggregate principal amount of its 8% Senior Subordinated Notes due 2012 (the “8% Notes”). The 8% Notes have no sinking fund requirements.
 
The 8% Notes bear interest at the rate of 8.0% per year, payable on February 1 and August 1 of each year. The 8% Notes will mature on February 1, 2012. The 8% Notes are unsecured obligations, 
 
 
16

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
jointly and severally guaranteed by CPI International and each of CPI’s domestic subsidiaries. The payment of all obligations relating to the 8% Notes are subordinated in right of payment to the prior payment in full in cash or cash equivalents of all senior debt (as defined in the indenture governing the 8% Notes) of CPI, including debt under the Senior Credit Facilities. Each guarantee of the 8% Notes is and will be subordinated to guarantor senior debt (as defined in the indenture governing the 8% Notes) on the same basis as the 8% Notes are subordinated to CPI’s senior debt.
 
At any time or from time to time on or after February 1, 2008, CPI, at its option, may redeem the 8% Notes, in whole or in part, at the redemption prices (expressed as percentages of principal amount) set forth below, together with accrued and unpaid interest thereon, if any, to the redemption date, if redeemed during the 12-month period beginning on February 1 of the years indicated below:
 
Year
 
Optional Redemption Price
 
2008
    104 %
2009
    102 %
2010 and thereafter
    100 %

Upon a change of control, CPI may be required to purchase all or any part of the 8% Notes for a cash price equal to 101% of the principal amount, plus accrued and unpaid interest thereon, if any, to the date of purchase.
 
The indenture governing the 8% Notes contains a number of covenants that, among other things, restrict, subject to certain exceptions, the ability of CPI and its restricted subsidiaries (as defined in the indenture governing the 8% Notes) to incur additional indebtedness, sell assets, consolidate or merge with or into other companies, pay dividends or repurchase or redeem capital stock or subordinated indebtedness, make certain investments, issue capital stock of their subsidiaries, incur liens and enter into certain types of transactions with their affiliates.
 
Events of default under the indenture governing the 8% Notes include: failure to make payments on the 8% Notes when due; failure to comply with covenants in the indenture governing the 8% Notes; a default under certain other indebtedness of CPI or any of its restricted subsidiaries that is caused by a failure to make payments on such indebtedness or that results in the acceleration of the maturity of such indebtedness; the existence of certain final judgments or orders against CPI or any of the restricted subsidiaries; and the occurrence of certain insolvency or bankruptcy events.
 
Floating Rate Senior Notes due 2015 of CPI International: As of March 28, 2008, after giving effect to the redemption of $6.0 million in principal amount of CPI International’s Floating Rate Senior Notes due 2015 (the “FR Notes”) on March 17, 2008, $16.0 million of aggregate principal remained outstanding under the FR Notes. The FR Notes were originally issued at a 1% discount. The FR Notes have no sinking fund requirements.
 
The FR Notes require interest payments at an annual interest rate, reset at the beginning of each semi-annual period, equal to the then six-month LIBOR plus 5.75%, payable semiannually on February 1 and August 1 of each year. The interest rate on the semi-annual interest payment due August 1, 2008 is 8.93625% per annum. CPI International may, at its option, elect to pay interest through the issuance of additional FR Notes for any interest payment date on or after August 1, 2006 and on or before February 1, 2010. If CPI International elects to pay interest through the issuance of additional FR Notes, the annual interest rate on the FR Notes will increase by an additional 1% step-up, with the step-up increasing by an                              
 
 
17

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
additional 1% for each interest payment made through the issuance of additional FR Notes (up to a maximum of 4%). The FR Notes will mature on February 1, 2015.

    The FR Notes are general unsecured obligations of CPI International. The FR Notes are not guaranteed by any of CPI International’s subsidiaries but are structurally subordinated to all existing and future indebtedness and other liabilities of CPI International’s subsidiaries. The FR Notes are senior in right of payment to CPI International’s existing and future indebtedness that is expressly subordinated to the FR Notes.
 
Because CPI International is a holding company with no operations of its own, CPI International relies on distributions from Communications & Power Industries to satisfy its obligations under the FR Notes. The Senior Credit Facilities and the indenture governing the 8% Notes restrict CPI’s ability to make distributions to CPI International. The Senior Credit Facilities prohibit CPI from making distributions to CPI International unless there is no default under the Senior Credit Facilities and CPI satisfies a senior secured leverage ratio of 3.75:1, and in the case of distributions to pay amounts other than interest on the FR Notes, the amount of the distribution and all prior such distributions do not exceed a specified amount. The indenture governing the 8% Notes prohibits CPI from making distributions to CPI International unless, among other things, there is no default under the indenture and the amount of the proposed dividend plus all previous Restricted Payments (as defined in the indenture governing the 8% Notes) does not exceed a specified amount.

At any time or from time to time on or after February 1, 2007, CPI International, at its option, may redeem the FR Notes in whole or in part at the redemption prices (expressed as percentages of principal amount) set forth below, together with accrued and unpaid interest thereon, if any, to the redemption date, if redeemed during the 12-month period beginning on February 1 of the years indicated below:
 
Year
 
Optional Redemption Price
 
2007
    103 %
2008
    102 %
2009
    101 %
2010 and thereafter
    100 %

Upon a change of control, as defined in the indenture governing the FR Notes, CPI International may be required to purchase all or any part of the outstanding FR Notes for a cash price equal to 101% of the principal amount, plus accrued and unpaid interest thereon, if any, to the date of purchase.
 
The indenture governing the FR Notes contains certain covenants that, among other things, limit the ability of CPI International and its restricted subsidiaries (as defined in the indenture governing the FR Notes) to incur additional indebtedness, sell assets, consolidate or merge with or into other companies, pay dividends or repurchase or redeem capital stock or subordinated indebtedness, make certain investments, issue capital stock of their subsidiaries, incur liens and enter into certain types of transactions with their affiliates.
 
Events of default under the indenture governing the FR Notes include: failure to make payments on the FR Notes when due; failure to comply with covenants in the indenture governing the FR Notes; a
 
 
18

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
default under certain other indebtedness of CPI International or any of its restricted subsidiaries that is caused by a failure to make payments on such indebtedness or that results in the acceleration of the maturity of such indebtedness; the existence of certain final judgments or orders against CPI International or any of the restricted subsidiaries; and the occurrence of certain insolvency or bankruptcy events.
 
Debt Maturities:    As of March 28, 2008, maturities on long-term debt were as follows:
 
 
Fiscal Year
 
Term Loan
   
8% Senior
Subordinated Notes
   
Floating Rate
Senior Notes
   
Total
 
2008 (remaining six months)
  $ 2,000     $ -     $ -     $ 2,000  
2009
    -       -       -       -  
2010
    -       -       -       -  
2011
    93,750       -       -       93,750  
2012
    -       125,000       -       125,000  
Thereafter
    -       -       16,000       16,000  
    $ 95,750     $ 125,000     $ 16,000     $ 236,750  

The above table assumes (1) that the respective debt instruments will be outstanding until their scheduled maturity dates, except for the Term Loan under the Senior Credit Facilities, which is assumed
to mature on the earlier date of August 1, 2011 as described above under “Senior Credit Facilities,” and (2) a debt level based on mandatory repayments according to the contractual amortization schedule. The above table also excludes any unplanned optional prepayments.
 
As of March 28, 2008, the Company was in compliance with the covenants under the indentures governing the 8% Notes and FR Notes and the agreements governing the Senior Credit Facilities, and the Company expects to remain in compliance with those covenants throughout the remainder of fiscal year 2008.
 
Loss on debt extinguishment: The redemption of $6.0 million in principal amount of the FR Notes on March 17, 2008, as discussed above, resulted in a loss on debt extinguishment of approximately $0.4 million, including non-cash write-offs of  $0.3 million of unamortized debt issue costs and issue discount costs and $0.1 million in cash payments primarily for call premiums.
 
Interest rate swap agreements:  See Note 6 for information on the interest rate swap agreements entered into by the Company to hedge the interest rate exposure associated with the Term Loan.
 
 
6.           Derivative Financial Instruments
 
The Company uses forward exchange contracts to hedge the foreign currency exposure associated with forecasted manufacturing costs in Canada. As of March 28, 2008, the Company had outstanding forward contract commitments to purchase Canadian dollars for an aggregate U.S. notional amount of $18.8 million; the last forward contract expires on September 29, 2008. At March 28, 2008 and September 28, 2007, the fair value of foreign currency forward contracts was a net asset of $67,000 and $1.3 million, respectively, and the unrealized gain, net of related tax expense, was $5,000 and $1.2 million, respectively.
 
 
19

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
The Company’s foreign currency forward contracts are designated as a cash flow hedge and are considered highly effective, as defined by SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities.” The unrealized gains and losses from foreign exchange forward contracts are included in “accumulated other comprehensive income” in the condensed consolidated balance sheets, and the Company anticipates recognizing the entire unrealized gain in operating earnings within the next 12 months. Changes in the fair value of foreign currency forward contracts due to changes in time value are excluded from the assessment of effectiveness, and are immediately recognized in general and administrative in the consolidated statements of operations. The time value was not material for the first two quarters of fiscal years 2008 and 2007. If the transaction being hedged fails to occur, or if a portion of any derivative is ineffective, then the Company promptly recognizes the gain or loss on the associated financial instrument in the consolidated statements of operations. No ineffective amounts were recognized due to anticipated transactions failing to occur in the first two quarters of fiscal years 2008 and 2007. Realized gains and losses from foreign currency forward contracts are recognized in cost of sales and general and administrative in the condensed consolidated statements of operations. Net income for the three and six months ended March 28, 2008 includes a recognized gain of $0.4 million from foreign currency forward contracts. Net income in the three and six months ended March 30, 2007 includes a recognized gain from foreign currency forward contracts of $0.1 million.

The Company also uses derivatives to hedge the interest rate exposure associated with its long- term debt. On September 21, 2007, the Company entered into an interest rate swap contract (the “2007 Swap”) to receive three-month USD-LIBOR-BBA (British Bankers’ Association) interest and pay 4.77% fixed rate interest. Net interest positions are settled quarterly. The Company has structured the 2007 Swap with decreasing notional amounts to match the expected pay down of its Term Loan under the Senior Credit Facilities discussed in Note 5. The notional value of the 2007 Swap was $85.0 million at March 28, 2008 and represented approximately 89% of the aggregate Term Loan balance. The Swap agreement is effective through June 30, 2011. Under the provisions of SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended, this arrangement was initially designated and qualified as an effective cash flow hedge of interest rate risk related to the Term Loan, which permitted recording the fair value of the 2007 Swap and corresponding unrealized gain or loss to accumulated other comprehensive income in the condensed consolidated balance sheets. The interest rate swap gain or loss is included in the assessment of hedge effectiveness. At March 28, 2008, the fair value of the short-term and long-term portions of the 2007 Swap was a liability of $1.8 million (accrued expenses) and $1.6 million (other long-term liabilities), respectively. At September 28, 2007, the fair value of the short-term and long-term portions of the 2007 Swap was an asset of $0.1 million (other current assets) and a liability of $0.3 million (other long-term liabilities), respectively. At March 28, 2008 and September 28, 2007, the unrealized loss, net of tax, was $2.1 million and $0.1 million, respectively.

 
20

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
7.           Commitments and Contingencies
 
Leases: The Company is committed to minimum rentals under non-cancelable operating lease agreements, primarily for land and facility space, that expire on various dates through 2050. Certain of the leases provide for escalating lease payments. Future minimum lease payments for all non-cancelable operating lease agreements at March 28, 2008 were as follows:
 
Fiscal Year
 
Operating Leases
 
2008 (remaining six months)
  $ 992  
2009
    1,435  
2010
    1,175  
2011
    507  
2012
    392  
Thereafter
    3,094  
Total future minimum lease payments
  $ 7,595  
 
Real estate taxes, insurance, and maintenance are also obligations of the Company. Rental expense under non-cancelable operating leases amounted to $0.6 million and $1.2 million for the three and six months ended March 28, 2008, respectively, and to $0.5 million and $1.0 million for the corresponding periods of fiscal year 2007. Assets subject to capital leases at March 28, 2008 and September 28, 2007 were not material.

Guarantees: The Company has restricted cash of $1.8 million and $2.3 million as of March 28, 2008 and September 28, 2007, respectively, consisting primarily of bank guarantees from customer advance payments to the Company’s international subsidiaries. The bank guarantees become unrestricted cash when performance under the sales or supply contract is complete. 

Purchase commitments: As of March 28, 2008, the Company had the following known purchase commitments, which include primarily future purchases for inventory-related items under various purchase arrangements as well as other obligations in the ordinary course of business that the Company cannot cancel or where it would be required to pay a termination fee in the event of cancellation:

Fiscal Year
 
Purchase Contracts
 
2008 (remaining six months)
  $ 31,071  
2009
    5,966  
2010
    388  
2011
    307  
Total purchase commitments
  $ 37,732  

Contingent Earnout Consideration: As discussed in Note 4, in addition to the $20.5 million of net cash consideration paid for the Malibu acquisition, there is a potential earnout payable to the former stockholders of Malibu of up to $14.0 million, which is primarily contingent upon the achievement of certain financial objectives over the three years following the acquisition, and a discretionary earnout of

 
21

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
up to $1.0 million contingent upon achievement of certain succession planning goals by June 30, 2010. The Company does not expect to make an earnout payment for fiscal year 2008.

Indemnification: As permitted under Delaware law, the Company has agreements whereby the Company indemnifies its officers, directors and certain employees for certain events or occurrences while the employee, officer or director is, or was serving, at the Company’s request in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has Director and Officer insurance policies that limit its exposure and may enable it to recover a portion of any future amounts paid.

The Company has entered into other standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company agrees to indemnify, defend, hold harmless, and to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company’s business partners or customers, in connection with any patent, copyright or other intellectual property infringement claim by any third party with respect to its products. The term of these indemnification agreements is generally perpetual after execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company has not incurred significant costs to defend lawsuits or settle claims related to these indemnification agreements. The Company believes that the estimated fair value of these agreements is minimal. Accordingly, the Company has no liabilities recorded for these agreements as of March 28, 2008.

Employment Agreements: The Company has entered into employment agreements with certain members of executive management that include provisions for the continued payment of salary, benefits and a pro-rata portion of annual bonus upon employment termination for periods ranging from 12 months to 30 months.

Contingencies: From time to time, the Company may be subject to claims that arise in the ordinary course of business. In the opinion of management, all such matters involve amounts that would not have a material adverse effect on the Company’s consolidated financial position if unfavorably resolved.
 
 
8.
Stock-based Compensation Plans
 
As of March 28, 2008, the Company had an aggregate of 1.2 million shares of its common stock available for future grant and approximately 3.4 million options that were outstanding under its various equity plans. Awards are subject to terms and conditions as determined by the Company’s Board of Directors.
 
 
22

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Stock Options: The following table summarizes stock option activity as of March 28, 2008, and changes during the six months ended March 28, 2008 under the Company’s stock option plans:

   
Oustanding Options
   
Exercisable Options
 
   
Number of Shares
   
Weighted-Average Exercise Price
   
Weighted-Average Remaining Contractual Term (Years)
   
Aggregate Intrinsic Value
   
Number of Shares
   
Weighted-Average Exercise Price
   
Weighted-Average Remaining Contractual Term (Years)
   
Aggregate Intrinsic Value
 
Balance at September 28, 2007
    3,171,081     $ 5.61       6.58     $ 42,513       2,259,528     $ 3.00       5.98     $ 36,184  
Granted
    208,750       16.79                                                  
Exercised
    -       -                                                  
Forfeited or cancelled
    -       -                                                  
Balance at March 28, 2008
    3,379,831     $ 6.30       6.30     $ 17,585       2,488,350     $ 3.43       5.61     $ 16,658  

The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of $9.98 as of March 28, 2008, which would have been received by the option holders had all option holders exercised their options as of that date. As of March 28, 2008, 2,411,100 exercisable options were in-the-money.

There were no options exercised during the three and six months ended March 28, 2008. During the three and six months ended March 30, 2007, cash received from option exercises was approximately $0.5 million, and the total intrinsic value of options exercised was $2.5 million and $2.8 million, respectively. As of March 28, 2008, there was approximately $5.0 million of total unrecognized compensation costs related to nonvested stock options, which is expected to be recognized over a weighted-average vesting period of 2.0 years.

Stock Purchase Plan:  Employees purchased 13,742 shares for $0.2 million and 26,743 shares for $0.4 million in the three and six months ended March 28, 2008, respectively, under the 2006 Employee Stock Purchase Plan (the “2006 ESPP”). As of March 28, 2008, there were no unrecognized compensation costs related to rights to acquire stock under the 2006 ESPP.

Restricted Stock and Restricted Stock Units: As of March 28, 2008 there were outstanding 120,254 shares of nonvested restricted stock and restricted stock units, and as of September 28, 2007 there were outstanding 11,466 shares of nonvested restricted stock, in each case granted to directors and employees. The restricted stock and restricted stock units vest over periods of one to four years and have a 10 year contractual life. Upon vesting, each restricted stock unit will automatically convert into one share of common stock of CPI International.

A summary of the status of the Company’s nonvested restricted stock and restricted stock unit awards as of March 28, 2008, and changes during the six months then ended is presented below:

   
Number of Shares
   
Weighted-Average Grant-Date Fair Value
 
Nonvested at September 28, 2007
    11,466     $ 17.44  
Granted
    114,461       15.22  
Vested
    (5,673 )     17.62  
Forfeited
    -       -  
Nonvested at March 28, 2008
    120,254     $ 15.32  

 
23

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Aggregate intrinsic value of the nonvested restricted stock and restricted stock unit awards at March 28, 2008 was $1.2 million. As of March 28, 2008, there was $1.7 million of total unrecognized compensation costs related to nonvested restricted stock and restricted stock units, which is expected to be recognized over a weighted average vesting period of 2.1 years.
 
The Company settles stock option exercises, restricted stock awards and restricted stock units with newly issued common shares.
 
 
Valuation and Expense Information under SFAS No. 123(R)
 
On October 1, 2005, the Company adopted SFAS No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123(R)”), which requires the measurement and recognition of compensation expense for all share-based payment awards made to the Company’s employees and directors, including employee stock options, restricted stock, restricted stock units and employee stock purchases related to the 2006 ESPP based on estimated fair values. The following table summarizes stock-based compensation expense for the three and six months ended March 28, 2008 and March 30, 2007, which was allocated as follows:
 
 
 
Three Months Ended
   
Six Months Ended
 
   
March 28, 2008
   
March 30,
2007
   
March 28,
2008
   
March 30,
2007
 
Share-based compensation cost recognized in the income statement by caption:
                   
Cost of sales
  $ 111     $ 63     $ 191     $ 102  
Research and development
    38       16       69       26  
Selling and marketing
    59       32       104       51  
General and administrative
    342       177       610       314  
    $ 550     $ 288     $ 974     $ 493  
                                 
Share-based compensation cost capitalized in inventory
  $ 119     $ 63     $ 215     $ 107  
Share-based compensation cost remaining in inventory at end of period
  $ 72     $ 36     $ 72     $ 36  
                                 
Share-based compensation expense by type of award:
                               
Stock options and stock purchase plan
  $ 433     $ 260     $ 807     $ 435  
Restricted stock and restricted stock units
    117       28       167       58  
    $ 550     $ 288     $ 974     $ 493  

The tax benefit realized from option exercises and restricted stock vesting totaled approximately $19,000 during the three and six months ended March 28, 2008. The tax benefit realized from option exercises and restricted stock vesting totaled approximately $1.0 million and $1.1 million during the three and six months ended March 30, 2007, respectively.

There were no stock options granted during the three months ended March 28, 2008. The weighted-average estimated fair value of stock options granted during the six months ended March 28,

 
24

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

2008 was $7.83 per share. The weighted-average estimated fair value of stock options granted during the three and six months ended March 30, 2007 was $9.07 and $7.69 per share, respectively. Assumptions used in the Black-Scholes model to estimate the fair value of stock option grants during each period are presented below.

   
Three Months Ended
   
Six Months Ended
 
   
March 28, 2008
   
March 30, 2007
   
March 28,
2008
   
March 30,
2007
 
Expected term (in years)
 
 *
 
      5.99       6.25       6.24  
Expected volatility
 
 *
        49.33 %     41.20 %     49.33 %
Risk-free rate
 
 *
        4.73 %     3.82 %     4.56 %
 Dividend yield  
 *
        0 %     0 %     0 %
* No new stock options were issued during the three months ended March 28, 2008.
 
 
Since the Company’s common stock has not been publicly traded for a sufficient time period, the expected volatility is based on expected volatilities of similar companies that have a longer history of being publicly traded. The risk-free rates are based on the U.S. Treasury yield in effect at the time of the grant. Since the Company’s historical data is limited, the expected term of options granted is based on the simplified method for plain vanilla options in accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 107. In December 2007, the SEC issued SAB No. 110, an amendment of SAB No. 107. SAB No. 110 states that the staff will continue to accept, under certain circumstances, the continued use of the simplified method beyond December 31, 2007. Accordingly, the Company will continue to use the simplified method until it has enough historical experience to provide a reasonable estimate of expected term.
 
Based on the 15% discount received by the employees, the weighted-average fair value of shares issued under the 2006 ESPP was $2.67 and $2.76 per share during the three and six months ended March 28, 2008, respectively, and $2.25 and $2.11 per share during the three and six months ended March 30, 2007, respectively.
 
Using the market price of the Company’s common stock on the date of grant, the weighted-average estimated fair value of restricted stock and restricted stock units granted was $10.98 and $15.22 per share during the three and six months ended March 28, 2008, respectively, and $9.07 per share during the three and six months ended March 30, 2007.

As stock-based compensation expense recognized in the condensed consolidated statement of operations for the three and six months ended March 28, 2008 and for the corresponding periods of fiscal year 2007 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS No. 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
 
9.           Income Taxes
 
The Company recorded an income tax provision of $4.1 million and $6.8 million for the six months ended March 28, 2008 and March 30, 2007, respectively. The Company’s effective tax rate was approximately 32% for the six months ended March 28, 2008 as compared to approximately 37% for the corresponding period of fiscal year 2007.
 
 
25

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
Income tax expense for the three months ended March 28, 2008 includes a tax benefit of approximately $0.4 million attributable to the correction of an immaterial error that arose in the fourth quarter of fiscal year 2007 relating to the warranty expense tax deduction at a foreign tax jurisdiction.
 
CPI International adopted FIN No. 48, “Accounting for Uncertainty in Income Taxes,” in the first quarter of fiscal year 2008 commencing on September 29, 2007.  In connection with the Company’s adoption of FIN No. 48, there was no cumulative effect adjustment necessary to the September 29, 2007 balance of retained earnings. The total unrecognized tax benefit was $6.8 million and $6.3 million as of March 28, 2008 and September 29, 2007, respectively, and is reported as a current liability (income taxes payable) since it is expected to be settled within 12 months of the reporting date. Of the total unrecognized tax benefit balance, $6.2 million and $5.7 million of unrecognized tax benefits would reduce the effective tax rate if recognized as of March 28, 2008 and September 29, 2007, respectively. The interest expense with uncertain tax positions are accrued as a component of income tax expense in the statements of operations and comprehensive income. As of March 28, 2008 and September 29, 2007, the Company had accrued $1.6 million and $1.3 million of interest, respectively. The Company had minimal penalties accrued in income tax expense.
 
    The Company is subject to U.S. federal, California, Massachusetts and Canada income tax as well as income tax in various other states, local and international jurisdictions. Fiscal years 2004 to 2007 remain open to examination by the foregoing major taxing jurisdictions to which the Company is subject, with the exception of California which is open from 2003 to 2007. The Company has not been audited for U.S. federal income tax matters. The Company has income tax audits in progress in Canada and in several states, local and international jurisdictions in which it operates. The years under examination by the Canadian taxing authorities are 2001 to 2002. The years under examination by other taxing authorities vary, with the earliest year being 2004.

Based on the outcome of examinations of the Company, the result of the expiration of statutes of limitations for specific jurisdictions, it is reasonably possible that the related unrecognized tax benefits could change from those recorded in the statement of financial position. The majority of the Company’s unrecognized tax benefit is attributable to the Canada Revenue Agency (“CRA”) income tax contingency. The CRA is conducting an audit of the Company’s income tax returns in Canada for fiscal years 2001 and 2002. The Company received a proposed tax assessment, including interest expense from the CRA for fiscal years 2001 and 2002. The tax assessment is based on tax deductions related to the valuation of the Satcom business, which was purchased by Communications & Power Industries Canada Inc. from CPI in fiscal years 2001 and 2002. While the Company believes that it has meritorious defenses and intends to vigorously defend its position, it is reasonably possible that the CRA may issue a formal tax assessment requiring the Company to settle the tax deficiency within 12 months. 
 
 
10.           Earnings Per Share
 
Basic earnings per share are computed using the weighted-average number of common shares outstanding during the period, excluding outstanding nonvested restricted shares subject to repurchase. Diluted earnings per share are computed using the weighted-average number of common and dilutive potential common equivalent shares outstanding during the period. Potential common equivalent shares consist of common stock issuable upon exercise of stock options and nonvested restricted shares using the treasury stock method.

 
26

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
The following table is a reconciliation of the shares used to calculate basic and diluted earnings per share (in thousands):

   
Three Months Ended
   
Six Months Ended
 
   
March 28, 2008
   
March 30,
2007
   
March 28,
2008
   
March 30,
2007
 
Weighted average common shares outstanding -- Basic
    16,387       16,253       16,379       16,161  
Effect of dilutive stock options and nonvested restricted stock awards and units
    1,269       1,477       1,365       1,485  
Weighted average common shares outstanding -- Diluted
    17,656       17,730       17,744       17,646  

The calculation of diluted net income per share excludes all anti-dilutive shares. For the three and six months ended March 28, 2008, the number of anti-dilutive shares, as calculated based on the weighted average price of the Company’s common stock for the periods, was approximately 0.9 million and 0.7 million shares, respectively. For the three and six months ended March 30, 2007, the number of anti-dilutive shares, as calculated based on the weighted average price of the Company’s common stock for the periods, was approximately 0.6 million and 0.5 million shares, respectively.
 
 
11.           Segments, Geographic and Customer Information

The Company’s reportable segments are VED and satcom equipment. The VED segment develops, manufactures and distributes high power/high frequency microwave and radio frequency signal components. The satcom equipment segment manufactures and supplies high power amplifiers and networks for satellite communication uplink and industrial applications. Segment information reported below is consistent with the manner in which it is reviewed and evaluated by the Company’s chief operating decision maker (“CODM”), its chief executive officer, and is based on the nature of the Company’s operations and products offered to customers.

Amounts not reported as VED or satcom equipment are reported as Other.  In accordance with quantitative and qualitative guidelines established by SFAS No. 131, Other includes the activities of the Company’s recently acquired Malibu division and unallocated corporate expenses, such as business combination-related expenses, share-based compensation expense, and certain non-recurring or unusual expenses. The Malibu division is a designer, manufacturer and integrator of advanced antenna systems for radar, radar simulators and telemetry systems, as well as for data links used in ground, airborne, UAV and shipboard systems.

 
27

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
Summarized financial information concerning the Company’s reportable segments is shown in the following tables:

   
Three Months Ended
   
Six Months Ended
 
   
March 28,
   
March 30,
   
March 28,
   
March 30,
 
   
2008
   
2007
   
2008
   
2007
 
 Sales to external customers
                       
 VED
  $ 73,744     $ 72,216     $ 137,734     $ 139,191  
 Satcom equipment
    17,134       16,228       34,709       32,976  
 Other
    3,926       -       8,271       -  
    $ 94,804     $ 88,444     $ 180,714     $ 172,167  
 Intersegment product transfers
                               
 VED
  $ 7,287     $ 4,582     $ 13,148     $ 9,705  
 Satcom equipment
    14       9       63       9  
    $ 7,301     $ 4,591     $ 13,211     $ 9,714  
 Capital expenditures
                               
 VED
  $ 502     $ 2,429     $ 1,344     $ 5,231  
 Satcom equipment
    210       22       654       22  
 Other
    159       25       560       94  
    $ 871     $ 2,476     $ 2,558     $ 5,347  
 EBITDA
                               
 VED
  $ 18,647     $ 17,932     $ 32,287     $ 35,516  
 Satcom equipment
    656       1,121       2,377       2,618  
 Other
    (3,460 )     (2,743 )     (6,899 )     (4,739 )
    $ 15,843     $ 16,310     $ 27,765     $ 33,395  

   
March 28,
   
 September 28,
   
2008
   
2007
 
Total assets
           
VED
  $ 333,284     $ 335,926  
Satcom equipment
    48,155       49,266  
Other
    85,986       91,030  
 
  $ 467,425     $ 476,222  

EBITDA represents earnings before provision for income taxes, net interest expense and depreciation and amortization. For the reasons listed below, the Company believes that GAAP-based financial information for leveraged businesses such as the Company’s business should be supplemented by EBITDA so that investors better understand the Company’s financial performance in connection with their analysis of the Company’s business:
 
 
EBITDA is a component of the measures used by the Company’s board of directors and management team to evaluate the Company’s operating performance;
 
 
28

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
 
 
the Senior Credit Facilities contain a covenant that requires the Company to maintain a senior secured leverage ratio that contains EBITDA as a component, and the Company’s management team uses EBITDA to monitor compliance with this covenant;
 
 
EBITDA is a component of the measures used by the Company’s management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between the Company’s operating results and those of competitors with different capital structures and therefore is a component of the measures used by the Company’s management to facilitate internal comparisons to competitors’ results and the Company’s industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by the Company of certain targets that contain EBITDA as a component.
 
Other companies may define EBITDA differently and, as a result, the Company’s measure of EBITDA may not be directly comparable to EBITDA of other companies. Although the Company uses EBITDA as a financial measure to assess the performance of its business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate the Company’s business. When analyzing the Company’s performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.
 
The following table reconciles net income to EBITDA:

   
Three Months Ended
   
Six Months Ended
 
   
March 28,
2008
   
March 30,
2007
   
March 28,
2008
   
March 30,
2007
 
Net income
  $ 6,154     $ 5,760     $ 8,664     $ 11,595  
Depreciation and amortization
    2,742       2,188       5,392       4,382  
Interest expense, net
    4,805       5,275       9,617       10,614  
Income tax expense
    2,142       3,087       4,092       6,804  
EBITDA
  $ 15,843     $ 16,310     $ 27,765     $ 33,395  
 
Net property, plant and equipment by geographic area was as follows:
 
   
March 28,
   
 September 28,
   
2008
   
 2007
 
United States
  $ 50,526     $ 51,704  
Canada
    14,247       14,308  
Other
    46       36  
    $ 64,819     $ 66,048  

With the exception of goodwill, the Company does not identify or allocate assets by operating segment, nor does its CODM evaluate operating segments using discrete asset information.

 
29

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
Goodwill by geographic area was as follows:
 
   
March 28,
   
 September 28,
   
2008
   
 2007
 
United States
  $ 114,221     $ 113,310  
Canada
    48,314       48,263  
    $ 162,535     $ 161,573  

The increase in goodwill from September 28, 2007 to March 28, 2008 was primarily due to a purchase price adjustment associated with the acquisition of Malibu. See Note 4.
 
Geographic sales by customer location were as follows for external customers:
 
   
Three Months Ended
   
Six Months Ended
 
   
March 28,
2008
   
March 30,
2007
   
March 28,
2008
   
March 30,
2007
 
United States
  $ 62,206     $ 52,577     $ 116,729     $ 102,081  
All foreign countries
    32,598       35,867       63,985       70,086  
Total sales
  $ 94,804     $ 88,444     $ 180,714     $ 172,167  

There were no individual foreign countries with sales greater than 10% of total sales for the `periods presented.

The U.S. Government is the only customer that accounted for 10% or more of the Company’s consolidated sales in the three and six months ended March 28, 2008 and in the corresponding periods of fiscal year 2007. Direct sales to the U.S. Government were $16.1 million and $30.9 million for the three and six months ended March 28, 2008, respectively, and $14.1 million and $29.0 million for the three and six months ended March 30, 2007, respectively. Accounts receivable from this customer represented 13% and 15% of consolidated accounts receivable as of March 28, 2008 and September 28, 2007, respectively.
 
 
12.           Subsequent Event

On April 1, 2008, the Company made another optional prepayment of $2.0 million on its Term Loan, further reducing the balance of the loan to $93.75 million. The $2.0 million brings the total Term Loan repayments made in fiscal year 2008 to $6.0 million, including those that were applied against the scheduled amortization payments for the first and second quarters of fiscal year 2008. Including the April 1, 2008 $2.0 million Term Loan prepayment and the redemption of $6.0 million in principal amount of CPI International’s FR Notes made in the second quarter of fiscal year 2008, the Company has made an aggregate of $12.0 million in repayments of its debt to date in fiscal year 2008.

 
30

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
 
13.           Supplemental Guarantors Condensed Consolidating Financial Information
 
On January 23, 2004, CPI issued $125.0 million of 8% Notes that are guaranteed by CPI International and all of CPI’s domestic subsidiaries. Separate financial statements of the guarantors are not presented because (i) the guarantors are wholly-owned and have fully and unconditionally guaranteed the 8% Notes on a joint and several basis and (ii) the Company’s management has determined that such separate financial statements are not material to investors. Instead, presented below are the consolidating financial statements of: (a) the parent, CPI International, (b) the issuer, CPI, (c) the guarantor subsidiaries (all of the domestic subsidiaries), (d) the non-guarantor subsidiaries, (e) the consolidating elimination entries, and (f) the consolidated totals. The accompanying consolidating financial information should be read in connection with the condensed consolidated financial statements of CPI International.
 
Investments in subsidiaries are accounted for based on the equity method. The principal elimination entries eliminate investments in subsidiaries, intercompany balances, intercompany transactions and intercompany sales.

 
31

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

CONDENSED CONSOLIDATING BALANCE SHEET
As of March 28, 2008


   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Assets
                                   
Cash and cash equivalents
  $ 184     $ 16,436     $ 800     $ 2,821     $ -     $ 20,241  
Restricted cash
    -       -       1,606       184       -       1,790  
Accounts receivable, net
    -       25,413       12,511       12,795       -       50,719  
Inventories
    -       43,400       7,299       16,925       (763 )     66,861  
Deferred tax assets
    -       9,260       -       688       -       9,948  
Intercompany receivable
    -       17,676       3,292       6,652       (27,620 )     -  
Prepaid and other current assets
    -       2,371       835       581       -       3,787  
Total current assets
    184       114,556       26,343       40,646       (28,383 )     153,346  
Property, plant and equipment, net
    -       47,349       3,184       14,286       -       64,819  
Deferred debt issue costs, net
    552       5,176       -       -       -       5,728  
Intangible assets, net
    -       57,550       14,683       7,968       -       80,201  
Goodwill
    -       92,557       21,715       48,263       -       162,535  
Other long-term assets
    -       424       272       100       -       796  
Intercompany notes receivable
    -       1,035       -       -       (1,035 )     -  
Investment in subsidiaries
    176,007       97,861       -       -       (273,868 )     -  
Total assets
  $ 176,743     $ 416,508     $ 66,197     $ 111,263     $ (303,286 )   $ 467,425  
                                                 
Liabilities and stockholders' equity
                                               
Current portion of long-term debt
  $ -     $ 2,000     $ -     $ -     $ -     $ 2,000  
Accounts payable
    249       10,874       2,860       7,866       -       21,849  
Accrued expenses
    230       18,038       3,260       4,517       -       26,045  
Product warranty
    -       2,630       501       1,821       -       4,952  
Income taxes payable
    -       (276 )     203       5,173       -       5,100  
Advance payments from customers
    -       6,698       3,841       1,116       -       11,655  
Intercompany payable
    27,620       -       -       -       (27,620 )     -  
Total current liabilities
    28,099       39,964       10,665       20,493       (27,620 )     71,601  
Deferred income taxes
    -       20,941       -       5,369       -       26,310  
Intercompany notes payable
    -       -       -       1,035       (1,035 )     -  
Long-term debt, less current portion
    15,873       218,750       -       -       -       234,623  
Other long-term liabilities
    -       1,923       -       197       -       2,120  
Total liabilities
    43,972       281,578       10,665       27,094       (28,655 )     334,654  
Common stock
    165       -       -       -       -       165  
Parent investment
    -       55,967       43,824       57,919       (157,710 )     -  
Additional paid-in capital
    70,165       -       -       -       -       70,165  
Accumulated other comprehensive (loss) income
    (2,265 )     (2,265 )     -       (220 )     2,485       (2,265 )
Retained earnings
    64,706       81,228       11,708       26,470       (119,406 )     64,706  
Total stockholders’ equity
    132,771       134,930       55,532       84,169       (274,631 )     132,771  
Total liabilities and stockholders' equity
  $ 176,743     $ 416,508     $ 66,197     $ 111,263     $ (303,286 )   $ 467,425  

 
32

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

CONDENSED CONSOLIDATING BALANCE SHEET
As of September 28, 2007

 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Assets
                                   
Cash and cash equivalents
  $ 1,378     $ 16,518     $ 958     $ 1,620     $ -     $ 20,474  
Restricted cash
    -       -       1,945       310       -       2,255  
Accounts receivable, net
    -       25,857       10,816       15,916       -       52,589  
Inventories
    -       43,949       7,092       17,084       (678 )     67,447  
Deferred tax assets
    -       9,272       3       469       -       9,744  
Intercompany receivable
    -       23,323       2,076       2,725       (28,124 )     -  
Prepaid and other current assets
    -       3,250       545       844       -       4,639  
Total current assets
    1,378       122,169       23,435       38,968       (28,802 )     157,148  
Property, plant and equipment, net
    -       48,327       3,382       14,339       -       66,048  
Deferred debt issue costs, net
    795       5,738       -       -       -       6,533  
Intangible assets, net
    -       67,008       6,465       8,270       -       81,743  
Goodwill
    -       107,462       5,848       48,263       -       161,573  
Other long-term assets
    -       3,077       -       100       -       3,177  
Intercompany notes receivable
    -       1,035       -       -       (1,035 )     -  
Investment in subsidiaries
    175,889       65,491       -       -       (241,380 )     -  
Total assets
  $ 178,062     $ 420,307     $ 39,130     $ 109,940     $ (271,217 )   $ 476,222  
                                                 
Liabilities and stockholders' equity
                                               
Current portion of long-term debt
  $ -     $ 1,000     $ -     $ -     $ -     $ 1,000  
Accounts payable
    224       10,421       2,430       8,719       -       21,794  
Accrued expenses
    404       16,695       3,991       5,259       -       26,349  
Product warranty
    -       3,141       481       1,956       -       5,578  
Income taxes payable
    -       1,888       562       6,298       -       8,748  
Advance payments from customers
    -       5,926       4,933       1,273       -       12,132  
Intercompany payable
    28,124       -       -       -       (28,124 )     -  
Total current liabilities
    28,752       39,071       12,397       23,505       (28,124 )     75,601  
Deferred income taxes
    31       22,833       -       5,530       -       28,394  
Intercompany notes payable
    -       -       -       1,035       (1,035 )     -  
Long-term debt, less current portion
    21,817       223,750       -       -       -       245,567  
Other long-term liabilities
    -       547       -       207       -       754  
Total liabilities
    50,600       286,201       12,397       30,277       (29,159 )     350,316  
Common stock
    164       -       -       -       -       164  
Parent investment
    -       60,705       19,167       57,746       (137,618 )     -  
Additional paid-in capital
    68,763       -       -       -       -       68,763  
Accumulated other comprehensive income
    1,110       1,059       -       155       (1,387 )     937  
Retained earnings
    57,425       72,342       7,566       21,762       (103,053 )     56,042  
Total stockholders’ equity
    127,462       134,106       26,733       79,663       (242,058 )     125,906  
Total liabilities and stockholders' equity
  $ 178,062     $ 420,307     $ 39,130     $ 109,940     $ (271,217 )   $ 476,222  

 
33

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
 For the Three Months Ended March 28, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 60,336     $ 21,125     $ 34,490     $ (21,147 )   $ 94,804  
 Cost of sales
    -       42,877       17,891       27,079       (21,109 )     66,738  
 Gross profit
    -       17,459       3,234       7,411       (38 )     28,066  
 Operating costs and expenses:
                                               
 Research and development
    -       729       272       1,929       -       2,930  
 Selling and marketing
    -       2,070       1,175       2,083       -       5,328  
 General and administrative
    -       3,817       1,018       657       -       5,492  
 Amortization of acquisition-related
                                               
 intangible assets
    -       100       531       150       -       781  
 Net loss on disposition of assets
    -       22       10       9       -       41  
 Total operating costs and expenses
    -       6,738       3,006       4,828       -       14,572  
 Operating income
    -       10,721       228       2,583       (38 )     13,494  
 Interest expense (income), net
    512       4,314       (17 )     (4 )     -       4,805  
 Loss on debt extinguishment
    393       -       -       -       -       393  
 (Loss) income before income tax expense
                                               
 and equity in income of subsidiaries
    (905 )     6,407       245       2,587       (38 )     8,296  
 Income tax (benefit) expense
    (344 )     2,741       (135 )     (120 )     -       2,142  
 Equity in income of subsidiaries
    6,715       3,049       -       -       (9,764 )     -  
 Net income
  $ 6,154     $ 6,715     $ 380     $ 2,707     $ (9,802 )   $ 6,154  
 
 

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
 For the Three Months Ended March 30, 2007
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 56,666     $ 16,351     $ 34,143     $ (18,716 )   $ 88,444  
 Cost of sales
    -       40,211       13,642       26,255       (19,369 )     60,739  
 Gross profit
    -       16,455       2,709       7,888       653       27,705  
 Operating costs and expenses:
                                               
 Research and development
    -       902       -       1,450       -       2,352  
 Selling and marketing
    -       2,015       869       1,915       -       4,799  
 General and administrative
    -       4,402       515       929       -       5,846  
 Amortization of acquisition-related
                                               
 intangible assets
    -       334       62       150       -       546  
 Net loss on disposition of assets
    -       17       -       23       -       40  
 Total operating costs and expenses
    -       7,670       1,446       4,467       -       13,583  
 Operating income
    -       8,785       1,263       3,421       653       14,122  
 Interest expense (income), net
    2,072       3,328       (9 )     (116 )     -       5,275  
 (Loss) income before income tax expense
                                               
 and equity in income of subsidiaries
    (2,072 )     5,457       1,272       3,537       653       8,847  
 Income tax (benefit) expense
    (787 )     2,650       356       868       -       3,087  
 Equity in income of subsidiaries
    7,045       4,238       -       -       (11,283 )     -  
 Net income
  $ 5,760     $ 7,045     $ 916     $ 2,669     $ (10,630 )   $ 5,760  

 
34

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
 For the Six Months Ended March 28, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 110,098     $ 40,951     $ 69,328     $ (39,663 )   $ 180,714  
 Cost of sales
    -       80,308       34,476       53,306       (39,578 )     128,512  
 Gross profit
    -       29,790       6,475       16,022       (85 )     52,202  
 Operating costs and expenses:
                                               
 Research and development
    -       1,621       421       3,612       -       5,654  
 Selling and marketing
    -       3,993       2,187       4,320       -       10,500  
 General and administrative
    -       7,535       2,088       2,022       -       11,645  
 Amortization of acquisition-related
                                               
 intangible assets
    -       668       593       301       -       1,562  
 Net loss on disposition of assets
    -       44       12       19       -       75  
 Total operating costs and expenses
    -       13,861       5,301       10,274       -       29,436  
 Operating income
    -       15,929       1,174       5,748       (85 )     22,766  
 Interest expense (income), net
    1,057       8,599       (37 )     (2 )     -       9,617  
 Loss on debt extinguishment
    393       -       -       -       -       393  
 (Loss) income before income tax expense
                                               
 and equity in income of subsidiaries
    (1,450 )     7,330       1,211       5,750       (85 )     12,756  
 Income tax (benefit) expense
    (551 )     3,482       119       1,042       -       4,092  
 Equity in income of subsidiaries
    9,563       5,715       -       -       (15,278 )     -  
 Net income
  $ 8,664     $ 9,563     $ 1,092     $ 4,708     $ (15,363 )   $ 8,664  

 
CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
 For the Six Months Ended March 30, 2007
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 108,031     $ 30,931     $ 68,686     $ (35,481 )   $ 172,167  
 Cost of sales
    -       75,706       25,707       52,681       (36,213 )     117,881  
 Gross profit
    -       32,325       5,224       16,005       732       54,286  
 Operating costs and expenses:
                                               
 Research and development
    -       1,545       -       2,698       -       4,243  
 Selling and marketing
    -       3,984       1,698       3,946       -       9,628  
 General and administrative
    -       8,093       722       1,435       -       10,250  
 Amortization of acquisition-related
                                               
 intangible assets
    -       668       125       301       -       1,094  
 Net loss on disposition of assets
    -       17       -       41       -       58  
 Total operating costs and expenses
    -       14,307       2,545       8,421       -       25,273  
 Operating income
    -       18,018       2,679       7,584       732       29,013  
 Interest expense (income), net
    4,120       6,619       (15 )     (110 )     -       10,614  
 (Loss) income before income tax expense
                                               
 and equity in income of subsidiaries
    (4,120 )     11,399       2,694       7,694       732       18,399  
 Income tax (benefit) expense
    (1,566 )     5,221       737       2,412       -       6,804  
 Equity in income of subsidiaries
    14,149       7,971       -       -       (22,120 )     -  
 Net income
  $ 11,595     $ 14,149     $ 1,957     $ 5,282     $ (21,388 )   $ 11,595  

 
35

 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Six Months Ended March 28, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Cash flows from operating activities
                                   
Net cash (used in) provided by operating activities
  $ (1,812 )   $ 1,779     $ 8,749     $ 1,723     $ -     $ 10,439  
Cash flows from investing activities
                                               
Capital expenditures
    -       (1,941 )     (95 )     (522 )     -       (2,558 )
Proceeds from adjustment to acquisition purchase price
    -       1,615       -       -       -       1,615  
Payment of patent application fees
    -       -       (147 )     -       -       (147 )
Net cash used in investing activities
    -       (326 )     (242 )     (522 )     -       (1,090 )
Cash flows from financing activities
                                               
Repayments of debt
    (6,000 )     (4,000 )     -       -       -       (10,000 )
Proceeds from issuance of common stock to employees
    418       -       -       -       -       418  
Intercompany dividends
    6,200       (6,200 )     -       -       -       -  
Net cash provided by (used in) financing activities
    618       (10,200 )     -       -       -       (9,582 )
Net (decrease) increase in cash and cash equivalents
    (1,194 )     (8,747 )     8,507       1,201       -       (233 )
Cash and cash equivalents at beginning of period
    1,378       16,518       958       1,620       -       20,474  
Cash and cash equivalents at end of period
  $ 184     $ 7,771     $ 9,465     $ 2,821     $ -     $ 20,241  

 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Six Months Ended March 30, 2007
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Cash flows from operating activities
                                   
Net cash (used in) provided by operating activities
  $ (563 )   $ 2,888     $ 239     $ 3,735     $ -     $ 6,299  
Cash flows from investing activities
                                               
Capital expenditures
    -       (1,634 )     (21 )     (3,692 )     -       (5,347 )
Capitalized expenses relating to potential business acquisition
    -       (119 )     -       -       -       (119 )
Net cash used in investing activities
    -       (1,753 )     (21 )     (3,692 )     -       (5,466 )
Cash flows from financing activities
                                               
Repayments of debt
    -       (5,000 )     -       -       -       (5,000 )
Proceeds from issuance of common stock to employees
    398       -       -       -       -       398  
Proceeds from exercise of stock options
    542       -       -       -       -       542  
Excess tax benefit on stock option exercises
    -       679       -       -       -       679  
Net cash provided by (used in) financing activities
    940       (4,321 )     -       -       -       (3,381 )
Net increase (decrease) in cash and cash equivalents
    377       (3,186 )     218       43       -       (2,548 )
Cash and cash equivalents at beginning of period
    139       28,299       290       1,425       -       30,153  
Cash and cash equivalents at end of period
  $ 516     $ 25,113     $ 508     $ 1,468     $ -     $ 27,605  

 
36

 
 
Item 2.        Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Our fiscal years are the 52- or 53-week periods that end on the Friday nearest September 30. Fiscal year 2008 comprises the 53-week period ending October 3, 2008 and fiscal year 2007 comprised the 52-week period ended September 28, 2007. The following discussion should be read in conjunction with the accompanying unaudited condensed consolidated financial statements, and the notes thereto, of CPI International, Inc.
 
 
Overview
 
CPI International, Inc., headquartered in Palo Alto, California, is the parent company of Communications & Power Industries, a provider of microwave, radio frequency, power and control solutions for critical defense, communications, medical, scientific and other applications. Communications & Power Industries develops, manufactures and distributes products used to generate, amplify and transmit high-power/high-frequency microwave and radio frequency signals and/or provide power and control for various applications. End-use applications of these systems include the transmission of radar signals for navigation and location; transmission of deception signals for electronic countermeasures; transmission and amplification of voice, data and video signals for broadcasting, Internet and other types of commercial and military communications; providing power and control for medical diagnostic imaging; and generating microwave energy for radiation therapy in the treatment of cancer and for various industrial and scientific applications.
 
Unless the context otherwise requires, “CPI International” means CPI International, Inc., and “CPI” means Communications & Power Industries, Inc. CPI is a direct subsidiary of CPI International. CPI International is a holding company with no operations of its own. The terms “we,” “us,” “our” and the “Company” refer to CPI International and its direct and indirect subsidiaries on a consolidated basis.
 
Acquisition of Malibu Research Associates, Inc.
 
On August 10, 2007, we completed the acquisition of all of the outstanding common stock of Malibu Research Associates, Inc. (“Malibu”). Malibu, headquartered in Camarillo, California, is a designer, manufacturer and integrator of advanced antenna systems for radar, radar simulators and telemetry systems, as well as for data links used in ground, airborne, unmanned aerial vehicles (“UAVs”) and shipboard systems. Under the terms of the purchase agreement, at the closing of the acquisition, we paid cash of approximately $22.4 million, which included $2.3 million and $1.0 million placed into indemnity and working capital escrow accounts, respectively. The indemnity escrow amount was provided to ensure funds are available to satisfy potential indemnification claims asserted prior to January 1, 2009, and the working capital escrow amount was provided to satisfy any negative differences between the estimated working capital amount as of the acquisition closing date and the actual working capital amount at the acquisition closing date.
 
For financial reporting purposes, consideration of approximately $2.6 million, which was part of the cash consideration paid for Malibu at the closing of the acquisiton, was excluded from the purchase price allocation and was reported as other long-term assets in the consolidated balance sheet at September 28, 2007.  This consideration amount represents the difference between the estimated working capital amount as of the acquisition closing date and the actual working capital amount as of the acquisition closing date. In accordance with SFAS No. 141, any contingent consideration that has not been determined beyond a reasonable doubt is excluded from the purchase price allocation until the contingency is resolved. We intended to make a claim against the working capital escrow account of $1.0
 
 
37

 
 
million and, if necessary, the indemnity escrow account of $2.3 million to recover the working capital shortfall once the amount of such shortfall had been finally determined.
 
    During the second quarter of fiscal year 2008, the valuation of Malibu’s net working capital amount as of the acquisition closing date was finalized, resulting in a disbursement of cash to us of $1.6 million from the escrow accounts. The remaining $1.0 million of consideration was allocated to goodwill as the working capital contingency was resolved, which resulted in an adjusted cash purchase price of $20.7 million.

Additionally, we may be required to pay a potential earnout to the former stockholders of Malibu of up to $14.0 million, which is primarily contingent upon the achievement of certain financial objectives over the three years following the acquisition; and a discretionary earnout of up to $1.0 million contingent upon achievement of certain succession planning goals.

Orders
 
We sell our products into six end markets: radar, electronic warfare, medical, communications, industrial and scientific.  Because they have similar characteristics, our radar and electronic warfare markets together are frequently referred to as “defense markets.”
 
Our customer sales contracts are recorded as orders when we accept written customer purchase orders or contracts. Customer purchase orders with an undefined delivery schedule, or blanket purchase orders, are not reported as orders until the delivery date is determined. Our government sales contracts are not reported as orders until we have been notified that the contract has been funded. Total orders for a fiscal period represent the total dollar amount of customer orders recorded by us during the fiscal period, reduced by the dollar amount of any order cancellations or terminations during the fiscal period.
 
Our orders by market for the six months ended March 28, 2008 and March 30, 2007 are summarized as follows (dollars in millions):

   
Six Months Ended
             
   
March 28, 2008
   
March 30, 2007
   
Increase (Decrease)
 
         
% of
         
% of
             
   
Amount
   
Orders
   
Amount
   
Orders
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 70.7       38 %   $ 76.3       41 %   $ (5.6 )     (7 ) %
Medical
    36.7       20       36.8       20       (0.1 )     -  
Communications
    55.9       30       54.6       30       1.3       2  
Industrial
    14.3       8       10.6       6       3.7       35  
Scientific
    7.6       4       5.9       3       1.7       29  
Total
  $ 185.2       100 %   $ 184.2       100 %   $ 1.0       1 %

In the six months ended March 28, 2008, our new Malibu division received orders totaling $11.6 million, of which approximately one-third was in the radar market and approximately two-thirds were in the communications market. As we acquired Malibu in August 2007, orders from the Malibu division are not included in our results for the six months ended March 30, 2007.
 
 
38

 
 
    Explanations for the order increase or decrease by market for the six months ended March 28, 2008 compared to the corresponding period of fiscal year 2007 are as follows:
 
·      
Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are for products for domestic and international defense and government end uses. Orders in these markets are characterized by many smaller orders in the $0.5 million to $3.0 million range by product or program, and the timing of these orders may vary from year to year. On a combined basis, orders for the radar and electronic warfare markets decreased approximately 7% from an aggregate of $76.3 million in the six months ended March 30, 2007 to an aggregate of $70.7 million in the six months ended March 28, 2008. The decrease in orders for these combined markets primarily resulted from decreased demand for radar products to support Aegis weapons system and continued delays in the placement of orders, and was partially offset by radar orders received by our recently acquired Malibu division.
 
Demand for our products to support ships with the Aegis weapons system has two components: we support new ship builds and we provide spare and repair products for previously fielded ships. Over the past several years, we have seen high demand for products to support a significant number of new ship builds for the Aegis weapons program for U.S. and international military customers. We have now received all orders for our products required to support these new ship builds. As a result, we expect the demand to be primarily for spare and repair products and, therefore, at overall lower levels than in the past several years. We expect demand for our products to increase again as the new ships are commissioned, deployed and added to the installed base, after which they will require spare and repair products.
 
During fiscal year 2008, we have been experiencing delays in the receipt of orders for radar and electronic warfare programs, which subsequently impacts the timing of our sales for these programs, and we expect these delays to continue for the foreseeable future.
 
·      
Medical: Orders for our medical products consist of orders for medical imaging applications, such as x-ray imaging, positron emission tomography (“PET”) and magnetic resonance imaging (“MRI”), and for radiation therapy applications for the treatment of cancer. Order levels in this market were essentially unchanged.
 
A Russian tender program in which we participated in fiscal years 2006 and 2007 will not recur in fiscal year 2008. In the six months ended March 30, 2007, we received approximately $1.4 million of the fiscal year’s $5.8 million in orders for the Russian tender program. In the six months ended March 28, 2008, the decrease in x-ray generator orders for this Russian tender program was offset by growth in orders for x-ray generators for international customers.
 
In fiscal year 2007, demand for products for MRI applications was very strong, as a large customer ordered a two-year supply of these products in one fiscal year, and we shipped a significant amount of these products during that fiscal year. As a result, in the first half of fiscal year 2008, orders for products for MRI applications decreased approximately $2.2 million. This decrease was partially offset by an increase in orders for products for radiation therapy applications.
 
·      
Communications: The 2% increase in communications orders was primarily attributable to telemetry orders received by our recently acquired Malibu division, as well as the receipt of our first production orders, totaling approximately $3 million, for Increment One of the
 
 
39

 
 
   
Warfighter Information Network Tactical (“WIN-T”) military communications program. These increases were partially offset by a decrease in orders for certain military communications programs, including WIN-T’s predecessor program, the Joint Network Node (“JNN”) military communications program, for which we had strong demand in the first six months of fiscal year 2007, and a decrease in orders for direct-to-home broadcast applications due to order timing. In the six months ended March 28, 2008, as the WIN-T program began to ramp up for production, orders to support the predecessor JNN program decreased $3.9 million due the completion of that program.  Once the WIN-T program is fully ramped up for production, we expect that our overall participation levels in the WIN-T program will be significantly higher than our participation levels in the previous JNN program.
 
·      
Industrial: Orders in the industrial market are cyclical. The $3.7 million increase in industrial orders was attributable to orders for products used in a wide variety of industrial applications, including industrial fabrication applications, international test systems and food processing, cargo screening and other industrial applications.
 
·      
Scientific: Orders in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $1.7 million increase in scientific orders was primarily the result of orders for products to support a new accelerator project for fusion research at an international scientific institute.  This increase was partially offset by decreases in orders for certain other scientific programs due to the timing of orders for those programs.
 
Incoming order levels fluctuate significantly on a quarterly or annual basis, and a particular quarter’s or year’s order rate may not be indicative of future order levels. In addition, our sales are highly dependent upon manufacturing scheduling and performance and, accordingly, it is not possible to accurately predict when orders will be recognized as sales.
 
Backlog
 
    As of March 28, 2008, we had an order backlog of $201.8 million compared to an order backlog of $196.4 million as of September 28, 2007. Approximately $3.0 million of the $5.4 million increase in backlog during the six months ended March 28, 2008 was due to orders at our recently acquired Malibu division. Because our orders for government end-use products generally have much longer delivery terms than our orders for commercial business (which require quicker turn-around), our backlog is primarily composed of government orders. As a result, we expect that our total backlog will not generally grow at the same rate as our total sales, because the markets where we are expecting higher growth (i.e., the medical and communications markets) are primarily commercial rather than government.

Backlog represents the cumulative balance, at a given point in time, of recorded customer sales orders that have not yet been shipped or recognized as sales. Backlog is increased when an order is received, and backlog is decreased when we recognize sales. We believe backlog and orders information is helpful to investors because this information may be indicative of future sales results. Although backlog consists of firm orders for which goods and services are yet to be provided, customers can, and sometimes do, terminate or modify these orders. However, historically the amount of modifications and terminations has not been material compared to total contract volume.
 
 
40

 
 
Results of Operations
 
We derive our revenue primarily from the sale of microwave and radio frequency products, including high-power microwave amplifiers, satellite communications amplifiers, medical x-ray imaging subsystems, and other related products. Our products generally have selling prices ranging from $2,000 to $100,000, with certain limited products priced up to $1,000,000.
 
Cost of goods sold generally includes costs for raw materials, manufacturing costs, including allocation of overhead and other indirect costs, charges for reserves for excess and obsolete inventory, warranty claims and losses on fixed price contracts. Operating expenses generally consist of research and development, selling and marketing and general and administrative expenses.
 
Three Months Ended March 28, 2008 Compared to Three Months Ended March 30, 2007
 
The following table sets forth our historical results of operations for each of the periods indicated (dollars in millions):
 
   
Three Months Ended
       
   
March 28, 2008
   
March 30, 2007
   
Increase (Decrease)
 
   
Amount
   
% of Sales
   
Amount
   
% of Sales
   
Amount
 
Sales
  $ 94.8       100.0 %   $ 88.4       100.0 %   $ 6.4  
Cost of sales
    66.7       70.4       60.7       68.7       6.0  
Gross profit
    28.1       29.6       27.7       31.3       0.4  
Research and development
    2.9       3.1       2.4       2.7       0.5  
Selling and marketing
    5.3       5.6       4.8       5.4       0.5  
General and administrative
    5.5       5.8       5.8       6.6       (0.3 )
Amortization of acquisition-
                                       
related intangibles
    0.8       0.8       0.5       0.6       0.3  
Net loss on disposition of assets
    -       -       -       -       -  
Operating income
    13.5       14.2       14.1       16.0       (0.6 )
Interest expense, net
    4.8       5.1       5.3       6.0       (0.5 )
Loss on debt extinguishment
    0.4       0.4       -       0.0       0.4  
Income before taxes
    8.3       8.7       8.8       10.0       (0.5 )
Income tax expense
    2.1       2.2       3.1       3.5       (1.0 )
Net income
  $ 6.2       6.5 %   $ 5.8       6.6 %   $ 0.4  
Other Data:
                                       
EBITDA (a)
  $ 15.8       16.7 %   $ 16.3       18.4 %   $ (0.5 )
 
Note:  Totals may not equal the sum of the component line items due to independent rounding. Percentages are calculated based on rounded dollar amounts presented.
 
(a)  
EBITDA represents earnings before provision for income taxes, net interest expense and depreciation and amortization. For the reasons listed below, we believe that GAAP-based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial performance in connection with their analysis of our business:
 
 
EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance;
 
 
our senior credit facilities contain covenants that require us to maintain certain interest expense coverage and leverage ratios that contain EBITDA as a component, and our management team uses EBITDA to monitor compliance with such covenants;
 
 
41

 
 
 
EBITDA is a component of the measures used by our management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and therefore is a component of the measures used by the management to facilitate internal comparisons to competitors' results and our industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component.
   
Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.
 
For a reconciliation of Net Income to EBITDA, see Note 11 of the accompanying unaudited condensed consolidated financial statements.
 
Sales. Our sales by market for the three months ended March 28, 2008 and March 30, 2007 are summarized as follows (dollars in millions):
 
   
Three Months Ended
             
   
March 28, 2008
   
March 30, 2007
   
Increase (Decrease)
 
   
Amount
   
% of Sales
   
Amount
   
% of Sales
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 40.5       43 %   $ 36.3       41 %   $ 4.2       12 %
Medical
    17.1       18       17.0       19       0.1       1  
Communications
    27.6       29       27.0       31       0.6       2  
Industrial
    6.6       7       6.4       7       0.2       3  
Scientific
    3.0       3       1.7       2       1.3       76  
Total
  $ 94.8       100 %   $ 88.4       100 %   $ 6.4       7 %

In the three months ended March 28, 2008, our new Malibu division generated sales totaling $3.9 million, of which approximately one-third was in the radar market and approximately two-thirds were in the communications market.  As we acquired Malibu in August 2007, sales from the Malibu division are not included in our results for the three months ended March 30, 2007.
 
Sales for the three months ended March 28, 2008 of $94.8 million were $6.4 million, or approximately 7%, higher than sales of $88.4 million for the second quarter of fiscal year 2007. Explanations for the sales increase or decrease by market for the second quarter of fiscal year 2008 compared to the second quarter of fiscal year 2007 are as follows:
 
·      
Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are for products for domestic and international defense and government end uses.  The timing of orders receipts and subsequent shipments in these markets may vary from year to year.  On a combined basis, sales for these two markets increased approximately 12% from $36.3 million in the second quarter of fiscal year 2007 to $40.5 million in the second quarter of fiscal year 2008, primarily due to increased sales of radar products to support the HAWK missile system and other military and weather radar systems, as well as sales of radar products by our recently acquired Malibu division.
 
·      
Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, PET and MRI, and for radiation therapy applications for the treatment of cancer. Sales levels in this market were essentially unchanged.
 
 
42

 
 
     
A Russian tender program in which we participated in fiscal years 2006 and 2007 will not recur in fiscal year 2008. The $0.6 million decrease in x-ray generator sales for this Russian tender program was offset by growth in sales for x-ray generators for international customers. We are beginning to see some softening in demand for x-ray generators for U.S. customers due to the impact of the phasing in of the Deficit Reduction Act of 2005 and currently challenging credit conditions.
 
In fiscal year 2007, demand for products for MRI applications was very strong, as a large customer ordered a two-year supply of these products in one fiscal year, and we shipped a significant amount of these products during that fiscal year. As a result, in the second quarter of fiscal year 2008, sales of products for MRI applications decreased approximately $0.4 million.
 
·      
Communications: The 2% increase in sales in the communications market was primarily the result of sales of telemetry products by our recently acquired Malibu division, as well as the start of our first production shipments for Increment One of the WIN-T military communications program and increased sales of satellite communications products for certain foreign broadcast network applications and military communications programs. These increases were partially offset by a decrease in sales of products for domestic direct-to-home applications as well as certain military communications programs, including the JNN program, for which we had strong sales in the three months ended March 30, 2007. In the three months ended March 28, 2008, we shipped $1.7 million in products to support the WIN-T military communications program as it began to ramp up for production. These sales were offset by a $1.7 million decrease in sales of products to support its predecessor, the JNN military communications program due to the completion of that program. We expect that our overall participation levels in the WIN-T program will be significantly higher than our participation levels in the previous JNN program.
 
·      
Industrial: Sales in the industrial market are cyclical. The $0.2 million increase in industrial sales was due to sales of products used in a wide variety of industrial applications.
 
·      
Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $1.3 million increase in scientific sales was primarily the result of increased product shipments for the Spallation Neutron Source at Oakridge National Laboratory. We received approximately $5 million in orders for this program in fiscal year 2007 and expect to complete our shipments of products for this program in the second quarter of fiscal year 2009.
 
Gross Profit. Gross profit was $28.1 million, or 29.6% of sales, for the three months ended March 28, 2008, a $0.4 million increase from $27.7 million, or 31.3% of sales, for the three months ended March 30, 2007.  The favorable gross profit increase was the result of the $6.4 million increase in sales volume for the three months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007, mostly offset by an increase in sales from engineering development programs that generally have lower gross margins. The weakness of the U.S. dollar for the three months ended March 28, 2008 as compared to the three months ended March 30, 2007 caused a reduction in gross profit of approximately $0.3 million from the translation of Canadian dollar denominated manufacturing expenses to U.S. dollars, net of currency hedging contracts. In addition to the above, we are beginning to see additional pricing pressures for certain programs and increases in material costs, both of which negatively impact gross margins.
 
 
43

 

    In fiscal year 2008, we engaged in a higher level of new product and engineering development programs than in fiscal year 2007 in order to continue to grow our business. These programs typically result in lower gross margins and higher period-to-period variability of our financial results. Notable new product and engineering development programs currently include Increment One of the WIN-T military communications program, the EarthCARE cloud-profiling program and products to support the Active Denial System, counter-improvised explosive device (“counter-IED”) systems, cargo screening programs, high-resolution nuclear magnetic resonance (“NMR”) programs, next generation weather radar systems and higher-power medical applications, as well as our recently acquired Malibu division’s advanced antenna programs, including programs for phased array systems, tactical common data links for UAVs and wideband ground antenna systems.
 
Research and Development. Research and development expenses were $2.9 million, or 3.1% of sales, for the three months ended March 28, 2008, a $0.5 million increase from $2.4 million, or 2.7% of sales, for the three months ended March 30, 2007. The increase in research and development expenses for the three months ended March 28, 2008 compared to the corresponding period of fiscal year 2007 was due primarily to increased spending of $0.3 million on medical diagnostic imaging products and $0.3 million in development expenses at our recently acquired Malibu division. Total spending on research and development, including customer-sponsored research and development, was $6.4 million and $4.2 million for the three months ended March 28, 2008 and March 30, 2007, respectively. Customer-sponsored research and development was $3.5 million and $1.8 million for the three months ended March 28, 2008 and March 30, 2007, respectively.
 
Selling and Marketing. Selling and marketing expenses were $5.3 million, or 5.6% of sales, for the three months ended March 28, 2008, a $0.5 million increase from the $4.8 million, or 5.4% of sales, for the three months ended March 30, 2007. The increase in selling and marketing expenses for the three months ended March 28, 2008 compared to the corresponding period of fiscal year 2007 reflects selling and marketing expenses of $0.4 million at our recently acquired Malibu division and the unfavorable impact of the weaker U.S. dollar on foreign-based expenses.
 
General and Administrative. General and administrative expenses were $5.5 million, or 5.8% of sales, for the three months ended March 28, 2008, a $0.3 million decrease from the $5.8 million, or 6.6% of sales, for the three months ended March 30, 2007. The reduction in general and administrative expenses in the three months ended March 28, 2008 was primarily due to favorable foreign currency translation of $0.4 million and $0.3 million of expenses incurred in the prior fiscal period associated with the evaluation of potential acquisition candidates that did not recur in the current fiscal period, partially offset by $0.5 million of administrative expenses for our recently acquired Malibu division. Foreign currency translation gains and losses are a result of the effect of exchange rate changes on certain foreign currency denominated balance sheet accounts translated into U.S. dollars.
 
Amortization of Acquisition-Related Intangibles. Amortization of acquisition-related intangibles consists of purchase accounting charges for technology and other intangible assets. Amortization of acquisition-related intangibles was $0.8 million for the three months ended March 28, 2008 and $0.5 million for the three months ended March 30, 2007.  The $0.3 million increase in amortization of acquisition-related intangibles is due to amortization of intangible assets for our recently acquired Malibu division.
 
Interest Expense, Net (“Interest Expense”). Interest Expense was $4.8 million, or 5.1% of sales, for the three months ended March 28, 2008, a $0.5 million decrease from the $5.3 million, or 6.0% of sales, for the three months ended March 30, 2007. The reduction in interest expense for the three months ended March 28, 2008 was primarily due to lower interest rates on our debt obligations during this period compared to the corresponding period of fiscal year 2007. The reduction in interest rates was
 
 
44

 

primarily due to the refinancing of our senior credit facilities and redemption of a portion of our floating rate senior notes during the fourth quarter of fiscal year 2007.
 
Loss on Debt Extinguishment. Loss on debt extinguishment of $0.4 million in the three months ended March 28, 2008 resulted from the early redemption of $6.0 million of our floating rate senior notes in March 2008.  The loss on debt extinguishment consists of $0.3 million in non-cash write-offs of deferred debt issue costs and issue discount costs and $0.1 million in cash payments for call premiums.
 
Income Tax Expense. We recorded income tax expense of $2.1 million and $3.1 million for the three months ended March 28, 2008 and March 30, 2007, respectively. Our effective tax rate was approximately 26% for the three months ended March 28, 2008 as compared to approximately 35% for the three months ended March 30, 2007.  The effective tax rate for the three months ended March 28, 2008 includes a discrete tax benefit of approximately $0.4 million that is attributable to the fourth quarter of fiscal year 2007 relating to the correction of an immaterial error in the computation of the warranty expense tax deduction.  
 
Net Income. Net income was $6.2 million, or 6.5% of sales, for the three months ended March 28, 2008 as compared to $5.8 million, or 6.6% of sales, in the three months ended March 30, 2007.  The $0.4 million increase in net income for the three months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007 was primarily due to additional gross profit from the $6.4 million increase in sales volume and lower income tax expense for the three months ended March 28, 2008, mostly offset by increased sales of products from engineering development programs with lower gross margins in the three months ended March 28, 2008 and higher operating expenses from the acquisition of Malibu.
 
EBITDA. EBITDA was $15.8 million, or 16.7% of sales, for the three months ended March 28, 2008 as compared to $16.3 million, or 18.4% of sales, for the three months ended March 30, 2007. The $0.5 million decrease in EBITDA for the three months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007 was primarily due to increased sales of products from engineering development programs with lower gross margins in the three months ended March 28, 2008.  These decreases to EBITDA were mostly offset by additional gross profit from the $6.4 million increase in sales volume.
 
 
45

 

Six Months Ended March 28, 2008 Compared to Six Months Ended March 30, 2007
 
The following table sets forth our historical results of operations for each of the periods indicated (dollars in millions):
 
   
Six Months Ended
       
   
March 28, 2008
   
March 30, 2007
   
Increase (Decrease)
 
   
Amount
   
% of Sales
   
Amount
   
% of Sales
   
Amount
 
Sales
  $ 180.7       100.0 %   $ 172.2       100.0 %   $ 8.5  
Cost of sales
    128.5       71.1       117.9       68.5       10.6  
Gross profit
    52.2       28.9       54.3       31.5       (2.1 )
Research and development
    5.7       3.2       4.2       2.4       1.5  
Selling and marketing
    10.5       5.8       9.6       5.6       0.9  
General and administrative
    11.6       6.4       10.3       6.0       1.3  
Amortization of acquisition-
                                       
related intangibles
    1.6       0.9       1.1       0.6       0.5  
Net loss on disposition of assets
    0.1       0.1       0.1       0.1       -  
Operating income
    22.8       12.6       29.0       16.8       (6.2 )
Interest expense, net
    9.6       5.3       10.6       6.2       (1.0 )
Loss on debt extinguishment
    0.4       0.2       -       0.0       0.4  
Income before taxes
    12.8       7.1       18.4       10.7       (5.6 )
Income tax expense
    4.1       2.3       6.8       3.9       (2.7 )
Net income
  $ 8.7       4.8 %   $ 11.6       6.7 %   $ (2.9 )
Other Data:
                                       
EBITDA (a)
  $ 27.8       15.4 %   $ 33.4       19.4 %   $ (5.6 )
 
Note:  Totals may not equal the sum of the component line items due to independent rounding. Percentages are calculated based on rounded dollar amounts presented.
 
(a)  
EBITDA represents earnings before provision for income taxes, net interest expense and depreciation and amortization. For the reasons listed below, we believe that GAAP-based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial performance in connection with their analysis of our business:
 
 
EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance;
 
 
our senior credit facilities contain covenants that require us to maintain certain interest expense coverage and leverage ratios that contain EBITDA as a component, and our management team uses EBITDA to monitor compliance with such covenants;
 
 
EBITDA is a component of the measures used by our management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and therefore is a component of the measures used by the management to facilitate internal comparisons to competitors' results and our industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component.
 
 
Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.
 
 
46

 
 
For a reconciliation of EBITDA to Net Income, see Note 11 of the accompanying unaudited condensed consolidated financial statements.
 
Sales. Our sales by market for the six months ended March 28, 2008 and March 30, 2007 are summarized as follows (dollars in millions):
 
   
Six Months Ended
             
   
March 28, 2008
   
March 30, 2007
   
Increase (Decrease)
 
   
Amount
   
% of Sales
   
Amount
   
% of Sales
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 75.9       42 %   $ 70.3       40 %   $ 5.6       8 %
Medical
    32.7       18       34.1       20       (1.4 )     (4 )
Communications
    54.4       30       53.1       31       1.3       2  
Industrial
    12.1       7       11.4       7       0.7       6  
Scientific
    5.6       3       3.3       2       2.3       70  
Total
  $ 180.7       100 %   $ 172.2       100 %   $ 8.5       5 %

In the six months ended March 28, 2008, our new Malibu division generated sales totaling $8.3 million, of which approximately 40 percent was in the radar market and approximately 60 percent was in the communications market.  As we acquired Malibu in August 2007, sales from the Malibu division are not included in our results for the first six months of fiscal year 2007.
 
Sales for the six months ended March 28, 2008 of $180.7 million were $8.5 million, or 5%, higher than sales of $172.2 million for the corresponding period of fiscal year 2007.  Explanations for the sales increase or decrease by market are as follows:
 
·      
Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are for products for domestic and international defense and government end uses. The timing of orders receipts and subsequent shipments in these markets may vary from year to year.  On a combined basis, sales for these two markets increased approximately 8% from $70.3 million in the six months ended March 30, 2007 to $75.9 million in the corresponding period of fiscal year 2008. The increase in sales was due primarily to sales of radar products by our recently acquired Malibu division and increased sales to support the HAWK missile system and other radar systems.
 
·      
Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, PET and MRI, and for radiation therapy applications for the treatment of cancer. The 4% decrease in sales of our medical products was primarily due to decreased sales of our products used in radiation therapy and decreased sales of our products used in MRI applications. The decrease in sales of radiation therapy products was primarily in the first quarter of fiscal year 2008. As expected, we received our annual large order for these radiation therapy products from a significant customer in the second quarter of fiscal year 2008.
 
In fiscal year 2007, demand for products for MRI applications was very strong, as a large customer ordered a two-year supply of these products in that year, and we shipped a significant amount of these products during that fiscal year. As a result, in the first six months of fiscal year 2008, sales of products for MRI applications decreased approximately $1.0 million.
 
 
47

 
 
    
A Russian tender program in which we participated in fiscal years 2006 and 2007 will not recur in fiscal year 2008. The decrease in x-ray generator sales for this Russian tender program was offset by growth in sales for x-ray generators for international customers. We are beginning to see some softening in demand for x-ray generators for U.S. customers due the impact of the phasing in of the Deficit Reduction Act of 2005 and currently challenging credit conditions, and sales of x-ray generators for U.S. customers in the first six months of fiscal year 2008 were $0.7 million lower than in the first six months of fiscal year 2007.
 
·      
Communications: The 2% increase in sales in the communications market was primarily the result of sales of telemetry products by our recently acquired Malibu division, as well as the start of our first production shipments for Increment One of the WIN-T military communications program and increased sales of satellite communications products for certain foreign broadcast network applications and military communications programs. These increases were partially offset by a decrease in sales of products for certain military communications programs, including the JNN program, certain foreign broadcast network applications and domestic direct-to-home applications for which we had strong sales in the first six months of fiscal year 2007.
 
In the six months ended March 28, 2008, the $1.7 million increase in sales of products to support the WIN-T military communications program as it began to ramp up for production was offset by a $2.4 million decrease in sales of products to support its predecessor, the JNN military communications program. We expect that our overall participation levels in the WIN-T program will be significantly higher than our participation levels in the previous JNN program.
 
·      
Industrial: Sales in the industrial market are cyclical.  The $0.7 million increase in industrial sales was due to sales of products used a wide variety of industrial applications.
 
·      
Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $2.3 million increase in scientific sales was primarily the result of increased product shipments for the Spallation Neutron Source at Oakridge National Laboratory. We received approximately $5 million in orders for this program in fiscal year 2007 and expect to complete our shipments of products for this program in the second quarter of fiscal year 2009.
 
Gross Profit. Gross profit was $52.2 million, or 28.9% of sales, for the six months ended March 28, 2008, a $2.1 million decrease from $54.3 million, or 31.5% of sales, in the six months ended March 30, 2007. For the six months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007, gross profit was unfavorably impacted by an increase in the sales of products from engineering development programs that generally have lower gross margins and the impact of the weaker U.S. dollar in the first six months of fiscal year 2008 as compared to the comparable period in fiscal year 2007, partially offset by gross profit resulting from the $8.5 million increase in sales volume. The weakness of the U.S. dollar for the six months ended March 28, 2008 as compared to the six months ended March 30, 2007 caused a reduction in gross profit of approximately $0.7 million from the translation of Canadian dollar denominated manufacturing expenses to U.S. dollars, net of currency hedging contracts. In addition to the above, we are beginning to see additional pricing pressures for certain programs and increases in material costs, both of which negatively impact gross margins.
 
In fiscal year 2008, we engaged in a higher level of new product and engineering development programs than in fiscal year 2007 in order to continue to grow our business.  These programs typically result in lower gross margins and higher period-to-period variability of our financial results.  Notable new
 
 
48

 
 
product and engineering development programs currently include Increment One of the WIN-T military communications program, the EarthCARE cloud-profiling program and products to support the Active Denial System, counter-IED systems, cargo screening programs, high-resolution NMR programs, next generation weather radar systems and higher-power medical applications, as well as our recently acquired Malibu division’s advanced antenna programs, including programs for phased array systems, tactical common data links for UAVs and wideband ground antenna systems.
 
        Research and Development. Research and development expenses were $5.7 million, or 3.2% of sales, for the six months ended March 28, 2008, a $1.5 million increase from $4.2 million, or 2.4% of sales, for the six months ended March 30, 2007.  The increase in research and development expenses for the six months ended March 28, 2008 compared to the corresponding period of fiscal year 2007 was due primarily to planned expenditures of $0.9 million on the Army's WIN-T program, and increased spending of $0.4 million on medical diagnostic imaging products and $0.4 million in development costs at our recently acquired Malibu division. Total spending on research and development, including company-sponsored amounts charged to research and development, and customer-sponsored amounts charged to cost of sales, increased to $12.9 million, or 7.1% of sales, in the first six months of fiscal year 2008 from $7.5 million, or 4.4% of sales, in the first six months of fiscal year 2007. Customer-sponsored research and development was $7.2 million and $3.3 million for the six months ended March 28, 2008 and March 30, 2007, respectively.
 
Selling and Marketing. Selling and marketing expenses were $10.5 million, or 5.8% of sales, for the six months ended March 28, 2008, a $0.9 million increase from the $9.6 million, or 5.6% of sales, for the six months ended March 30, 2007.  The increase in selling and marketing expenses for the six months ended March 28, 2008 compared to the corresponding period of fiscal year 2007 reflects selling and marketing expenses of $0.5 million at our recently acquired Malibu division, as well as the unfavorable impact of the weaker U.S. dollar on foreign-based expenses.
 
General and Administrative. General and administrative expenses were $11.6 million, or 6.4% of sales, for the six months ended March 28, 2008, a $1.3 million increase from the $10.3 million, or 6.0% of sales, for the six months ended March 30, 2007. The increase in general and administrative expenses in the six months ended March 28, 2008 was primarily due to $1.2 million of expenses for our recently acquired Malibu division, $0.3 million less of favorable foreign currency translation and higher stock compensation expense of $0.3 million, partially offset by lower expenses of $0.5 million associated with the evaluation of potential acquisition candidates in fiscal year 2007. Foreign currency translation gains and losses are a result of the effect of exchange rate changes on certain foreign currency denominated balance sheet accounts translated into U.S. dollars.
 
Amortization of Acquisition-Related Intangibles. Amortization of acquisition-related intangibles consists of purchase accounting charges for technology and other intangible assets. Amortization of acquisition-related intangibles was $1.6 million for the six months ended March 28, 2008 and $1.1 million for the six months ended March 30, 2007.  The $0.5 million increase in amortization of acquisition-related intangibles is due to amortization of intangible assets for our recently acquired Malibu division.

Interest Expense, Net (“Interest Expense”). Interest Expense of $9.6 million for the six months ended March 28, 2008 was $1.0 million lower than interest expense of $10.6 million for the six months ended March 30, 2007. The reduction in interest expense for the six months ended March 28, 2008 was primarily due to lower interest rates on our debt obligations during the 2008 period compared to the corresponding period of fiscal year 2007.  The reduction in interest rates was primarily due to the refinancing of our senior credit facilities and redemption of a portion of our floating rate senior notes during the fourth quarter of fiscal year 2007.
 
 
49

 
 
Loss on Debt Extinguishment. Loss on debt extinguishment of $0.4 million in the six months ended March 28, 2008 resulted from the early redemption of $6.0 million of our floating rate senior notes in March 2008.  The loss on debt extinguishment consists of $0.3 million in non-cash write-offs of deferred debt issue costs and issue discount costs and $0.1 million in cash payments for call premiums.
 
Income Tax Expense. We recorded income tax expense of $4.1 million and $6.8 million for the six months ended March 28, 2008 and March 30, 2007, respectively. Our effective tax rate was approximately 32% for the six months ended March 28, 2008 as compared to approximately 37% for the corresponding period of fiscal year 2007. The lower effective income tax rate in the six months ended March 28, 2008 is primarily due to a discrete tax benefit in the six months ended March 28, 2008 of $0.4 million related to the correction of an immaterial error that arose in the fourth quarter of fiscal year 2007, and also due to lower Canadian statutory income tax rates in the six months ended March 28, 2008.
 
Income tax expense for the six months ended March 28, 2008 includes a tax benefit of approximately $0.4 million that is attributable to the fourth quarter of fiscal year 2007 relating to the correction of an error in the computation of the warranty expense tax deduction in a foreign tax jurisdiction. Our estimated effective income tax rate for the second half of fiscal year 2008 is expected to be approximately 37%.
 
Net Income. Net income was $8.7 million, or 4.8% of sales, for the six months ended March 28, 2008 as compared to $11.6 million, or 6.7% of sales, in the six months ended March 30, 2007.  The $2.9 million decrease in net income for the six months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007 was primarily due to increased sales of products from engineering development programs with lower gross margins in the six months ended March 28, 2008, increased spending on research and development, and the unfavorable impact from the translation of Canadian dollar denominated expenses to the U.S. dollar. These decreases to net income were partially offset by additional gross profit resulting from the $8.5 million increase in sales volume and lower interest expense in the six months ended March 28, 2008.
 
EBITDA. EBITDA was $27.8 million, or 15.4% of sales, for the six months ended March 28, 2008 as compared to $33.4 million, or 19.4% of sales, for the six months ended March 30, 2007. The $5.6 million decrease in EBITDA for the six months ended March 28, 2008 as compared to the corresponding period of fiscal year 2007 was primarily due to increased sales of products from engineering development programs with lower gross margins in the six months ended March 28, 2008, increased spending on research and development, and the unfavorable impact from the translation of Canadian dollar denominated expenses to the U.S. dollar.  These decreases to EBITDA were partially offset by additional gross profit resulting from the $8.5 million increase in sales volume.
 
 
50

 

Liquidity and Capital Resources
 
Overview
 
Our liquidity is affected by many factors, some of which are based on normal ongoing operations of our business and others that are related to uncertainties in the markets in which we compete and other global economic factors. We have historically financed, and intend to continue to finance, our capital and working capital requirements, including debt service and internal growth, through a combination of cash flows from our operations and borrowings under our senior credit facilities. Our primary uses of cash are cost of sales, operating expenses, debt service and capital expenditures.
 
We believe that we have the financial resources to meet our business requirements for the next 12 months, including capital expenditures and working capital requirements.
 
Cash and Working Capital
 
The following summarizes our cash and cash equivalents and working capital (in thousands):
 
   
March 28,
2008
   
  September 28,
2007
Cash and cash equivalents
  $ 20,241     $ 20,474  
Working capital
    81,745       81,547  
 
We invest cash balances in excess of operating requirements in overnight U.S. Government securities and money market accounts. In addition to the above cash and cash equivalents, we had restricted cash of $1.8 million as of March 28, 2008, consisting primarily of bank guarantees from customer advance payments to our international subsidiaries. The bank guarantees become unrestricted cash when performance under the sales or supply contract is complete.
 
The significant factors underlying the $0.2 million net decrease in cash and cash equivalents during the six months ended March 28, 2008 were the repayment of $4.0 million of the outstanding balance on our senior term loan, the redemption of $6.0 million in principal amount of our floating rate senior notes and capital expenditures of $2.6 million, partially offset by net cash provided by our operating activities of $10.4 million and a purchase price adjustment of $1.6 million for the Malibu acquisition.
 
We had total principal amount of debt outstanding of $236.75 million and $246.75 million as of March 28, 2008 and September 28, 2007, respectively. As of March 28, 2008, we had borrowing availability of $54.1 million under the revolver under our senior credit facilities.
 
As of April 1, 2008, after giving effect to an optional prepayment of 2.0 million on our senior term loan on such date, we had $234.75 million in total principal amount of debt outstanding,

Historical Operating, Investing and Financing Activities
 
Operating Activities
 
During the six months ended March 28, 2008 and March 30, 2007, we funded our operating activities through cash generated internally.
 
 
51

 
 
Operating activities provided cash of $10.4 million in the six months ended March 28, 2008, which was attributable to net income of $8.7 million and depreciation, amortization and other non-cash charges of $6.2 million, partially offset by $4.5 million for cash used for working capital. The primary uses of cash for working capital in the first six months of fiscal year 2008 were for reduction in income taxes payable of $3.6 million and a decrease in accrued expenses, including product warranty reserve, of $2.8 million, partially offset by $1.9 million decrease in accounts receivable.
 
Operating activities provided cash of $6.3 million in the six months ended March 30, 2007, which was attributable to net income of $11.6 million and depreciation, amortization and other non-cash charges of $5.4 million, partially offset by $10.7 million for cash used for working capital. The primary uses of cash for working capital in the first six months of fiscal year 2007 were for reduction in income taxes payable of $4.6 million due primarily to income tax payments from the taxable gain on the sale of our San Carlos property in fiscal year 2006, and increases in accounts receivable of $3.3 million and inventories of $2.8 million due to the timing of customer shipments.
 
 Investing Activities
 
For the six months ended March 28, 2008, net cash used in investing activities was $1.1 million, compared to $5.5 million for the six month ended March 30, 2007.
 
Investing activities for the six months ended March 28, 2008 consisted primarily of $2.6 million capital expenditures and $0.1 million payment of patent application fees. The amount of cash used in investing activities was partially offset by cash received as a result of a $1.6 million adjustment to the purchase price of Malibu based on the actual working capital of Malibu as of the acquisition closing date.
 
Investing activities for the six months ended March 30, 2007 consisted primarily of $5.4 million capital expenditures and $0.1 million of capitalized expenses relating to a potential business acquisition. Capital expenditures in the first six months of fiscal year 2007 included $3.5 million for a building expansion project for our Canadian manufacturing facility.
 
Financing Activities
 
For the six months ended March 28, 2008, net cash used in financing activities was $9.6 million, compared to $3.4 million for the six month ended March 30, 2007.
 
Net cash used in financing activities for the six months ended March 28, 2008 consisted primarily of a redemption of $6.0 million in principal amount of our floating rate senior notes and a term loan repayment of $4.0 million. The $4.0 million term loan repayment during the first six months of fiscal year 2008 comprised the scheduled amortization payment of $250,000 for each of the first and second quarters of fiscal year 2008 and an optional prepayment of $3.5 million. The cash used in financing activities for the first six months of fiscal year 2008 was partially offset by $0.4 million in proceeds from employee stock purchases.
 
Financing activities for the six months ended March 30, 2007 consisted primarily of a $5.0 million term loan repayment in December 2006 using available operating cash, partially offset by proceeds of $0.5 million from the exercise of stock options and $0.4 million from employee stock purchases, and $0.7 million of excess tax benefits from stock option exercises. The $5.0 million term loan repayment included a $1.7 million required annual excess cash flow prepayment for fiscal year 2006 and an optional prepayment of $3.3 million.
 
 
52

 
 
If the leverage ratio under our amended and restated senior credit facilities exceeds 3.5:1 at the end of any fiscal year, then we are required to make an annual prepayment within 90 days after the end of the fiscal year based on a calculation of excess cash flow, as defined in the senior credit facilities, multiplied by a factor of 50%, less any optional prepayments made during the fiscal year. There was no excess cash flow payment due for fiscal year 2007, and, therefore, no excess cash flow payment was made in the six months ended March 28, 2008.
 
 
Capital Expenditures
 
Our continuing operations typically do not have large recurring capital expenditure requirements. Capital expenditures are generally made to replace existing assets, increase productivity, facilitate cost reductions or meet regulatory requirements. Total capital expenditures for the six month ended March 28, 2008 were $2.6 million. We expect total fiscal year 2008 capital expenditures to be approximately $5.0 to $6.0 million.
 
 
Recently Released Accounting Pronouncements
 
In June 2006, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation (“FIN”) No. 48, “Accounting for Income Tax Uncertainties.” FIN No. 48 defines the threshold for recognizing the benefits of tax return positions in the financial statements as “more-likely-than-not” to be sustained by the taxing authority. The recently issued literature also provides guidance on the derecognition, measurement and classification of income tax uncertainties, along with any related interest and penalties. FIN No. 48 also includes guidance concerning accounting for income tax uncertainties in interim periods and increases the level of disclosures associated with any recorded income tax uncertainties. Effective September 29, 2007, we adopted FIN No. 48. The adoption of FIN No. 48 did not have any impact on our financial position, net income or prior year financial statements. See Note 9, "Income Taxes," to the consolidated condensed financial statements included in this Form 10-Q for further discussion.

In September 2006, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value under other accounting pronouncements that permit or require fair value measurements, changes the methods used to measure fair value and expands disclosures about fair value measurements. In particular, disclosures are required to provide information on: the extent to which fair value is used to measure assets and liabilities; the inputs used to develop measurements; and the effect of certain of the measurements on earnings (or changes in net assets). SFAS No. 157 is effective for fiscal years beginning after November 15, 2007 for financial assets and liabilities and for fiscal years beginning after November 15, 2008 for non-financial assets and liabilities. Early adoption, as of the beginning of an entity’s fiscal year, is also permitted, provided interim financial statements have not yet been issued. We will be required to adopt SFAS No. 157 in our fiscal year 2009 commencing October 4, 2008 for financial assets and liabilities and in our fiscal year 2010 commencing October 2, 2009 for non-financial assets and liabilities. We are currently evaluating the potential impact, if any, that the adoption of this new standard will have on our consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB Statement No. 115.” SFAS No. 159 permits companies to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. The objective of SFAS No. 159 is to provide opportunities to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply hedge accounting provisions. SFAS No. 159 also establishes

 
53

 
 
presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. We will be required to adopt SFAS No. 159 in our fiscal year 2009 commencing October 4, 2008 and are currently evaluating the impact, if any, that the adoption of this new standard will have on our consolidated financial statements.
 
     In December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statement—amendments of ARB No. 51.” SFAS No. 160 states that accounting and reporting for minority interests will be recharacterized as noncontrolling interests and classified as a component of equity. SFAS No. 160 also establishes reporting requirements that provide sufficient disclosures that clearly identify and distinguish between the interests of the parent and the interests of the noncontrolling owners. SFAS No. 160 applies to all entities that prepare consolidated financial statements, except not-for-profit organizations, but will affect only those entities that have an outstanding noncontrolling interest in one or more subsidiaries or that deconsolidate a subsidiary. SFAS No. 160 is effective for fiscal years beginning after December 15, 2008. We will be required to adopt SFAS No. 160 in our fiscal year 2010 commencing October 3, 2009 and are currently evaluating the impact, if any, that the adoption of this new standard will have on our consolidated financial statements.
 
     In December 2007, the FASB issued SFAS No. 141 (revised 2007) (“SFAS No. 141(R)”), “Business Combinations,” which replaces SFAS No. 141. SFAS No. 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any non controlling interest in the acquiree and the goodwill acquired. The Statement also establishes disclosure requirements which will enable users to evaluate the nature and financial effects of the business combination. SFAS No. 141(R) is effective for fiscal years beginning after December 15, 2008. We will be required to adopt SFAS No. 141(R) in our fiscal year 2010 commencing October 3, 2009 and are currently evaluating the impact, if any, that the adoption of this new standard will have on our consolidated financial statements.
 
     In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133.” SFAS No. 161 requires enhanced disclosures about an entity’s derivative instruments and hedging activities including: (1) how and why an entity uses derivative instruments; (2) how derivative instruments and related hedged items are accounted for under SFAS No. 133 and its related interpretations; and (3) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with earlier application encouraged. We will be required to adopt SFAS No. 161 in our second quarter of fiscal year 2009 commencing January 3, 2009 and are currently evaluating the impact, if any, that the adoption of this new standard will have on our consolidated financial statements.

 
Critical Accounting Policies and Estimates
 
Our consolidated financial statements are prepared in accordance with generally accepted accounting principles, or GAAP, in the United States of America, which require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon various factors and information available to us at the time that these estimates, judgments and assumptions are made. These factors and information may include, but are not limited to, history and prior experience, experience of other enterprises in the same industry, new related events, current economic conditions and information from third party professionals. The estimates, judgments and assumptions we make can affect the reported amounts of  assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the
 
 
54

 
 
periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, our financial statements will be affected.
 
We believe the following critical accounting policies are the most significant to the presentation of our financial statements and require the most subjective and complex judgments. These matters, and the judgments and uncertainties affecting them, are also essential to understanding our reported and future operating results.
 
Revenue recognition
 
We generally recognize revenue upon shipment of product, following receipt of written purchase orders, when the price is fixed or determinable, title has transferred and collectibility is reasonably assured. Value of sales under the percentage of completion method of accounting is determined on the basis of costs incurred and estimates of costs at completion, which require management estimates of future costs. Changes in estimated costs at completion over time could have a material impact on our operating results.
 
Inventory reserves
 
We assess the valuation of inventory and periodically write down the value for estimated excess and obsolete inventory based upon actual usage and estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Management personnel play a key role in our excess inventory review process by providing updated sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory. If our estimates regarding demand are inaccurate or changes in technology affect demand for certain products in an unforeseen manner, we may incur losses or gains in excess of our established markdown reserve that could be material.
 
Management also reviews the carrying value of inventory for lower of cost or market on an individual product or contract basis. A loss reserve is charged to cost of sales if the estimated product cost or the contract cost at completion is in excess of net realizable value (selling price less estimated cost of disposal). If the actual contract cost at completion is different than originally estimated, then a loss or gain provision adjustment would be recorded that could have a material impact on our operating results.

Product warranty
 
Our products are generally warranted for a variety of periods, typically one to three years or a predetermined product usage life. A provision for estimated future costs of repair, replacement or customer accommodations is reflected in the consolidated condensed financial statements included in this report. We assess the adequacy of our preexisting warranty liabilities and adjust the balance based on actual experience and changes in future expectations. The determination of product warranty reserves requires us to make estimates of product return rates and expected cost to repair or replace the products under warranty. If actual repair and replacement costs differ significantly from our estimates, then adjustments to recognize additional cost of sales may be required.
 
Business combination and related goodwill and intangibles
 
We account for business combinations using the purchase method of accounting pursuant to SFAS No. 141, "Business Combinations." Intangible assets acquired in a purchase method business
 
 
55

 
 
combination are recognized and reported apart from goodwill, pursuant to the criteria specified by SFAS No. 141.
 
Accounting for business combinations requires the allocation of purchase price to identifiable tangible and intangible assets and liabilities based upon their fair value. The allocation of purchase price is a matter of judgment and requires the use of estimates and fair value assumptions. The allocation of purchase price to finite-lived assets can have a significant impact on operating results because finite-lived assets are depreciated or amortized over their remaining useful lives.
 
The values assigned to acquired identifiable intangible assets for technology were determined based on the excess earnings method of the income approach. This method determines fair market value using estimates and judgments regarding the expectations of future after-tax cash flows from those assets over their lives, including the probability of expected future contract renewals and sales, all of which are discounted to their present value.
 
Recoverability of long-lived assets
 
We account for goodwill and other intangible assets in accordance with SFAS No. 142, "Goodwill and Other Intangible Assets." SFAS No. 142 requires that goodwill and identifiable intangible assets with indefinite useful lives be tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives and reviewed for impairment in accordance with SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." We amortize identifiable intangible assets on a straight-line basis over their useful lives of up to 50 years.
 
We assess the recoverability of the carrying value of goodwill and other intangible assets with indefinite useful lives at least annually or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of goodwill is measured at the reporting unit level (our six divisions) based on a two-step approach. First, the carrying amount of the reporting unit is compared to the fair value as estimated by the future net discounted cash flows expected to be generated by the reporting unit. To the extent that the carrying value of the reporting unit exceeds the fair value of the reporting unit, a second step is performed, wherein the reporting unit's assets and liabilities are valued. The implied fair value of goodwill is calculated as the fair value of the reporting unit in excess of the fair value of all non-goodwill assets and liabilities allocated to the reporting unit. To the extent the reporting unit's carrying value of goodwill exceeds its implied fair value, impairment exists and must be recognized. This process requires the use of discounted cash flow models that utilize estimates of future revenue and expenses as well as the selection of appropriate discount rates. There is inherent uncertainty in these estimates, and changes in these factors over time could result in an impairment charge.
 
At March 28, 2008 and September 28, 2007, the carrying amount of goodwill and other intangible assets, net was $242.7 million and $243.3 million, respectively. As of March 28, 2008, no significant changes in the underlying business assumptions or circumstances that drive the impairment analysis led us to believe that goodwill might have been impaired. We will continue to evaluate the need for impairment if changes in circumstances or available information indicate that impairment may have occurred, and at least annually in the fourth quarter.
 
At March 28, 2008 and September 28, 2007, the carrying amount of property, plant and equipment was $64.8 million and $66.0 million, respectively. We assess the recoverability of property, plant and equipment to be held and used by a comparison of the carrying amount of an asset or group of
 
 
56

 
 
assets to the future net undiscounted cash flows expected to be generated by the asset or group of assets. If such assets are considered impaired, then the impairment recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. This process requires the use of cash flow models that utilize estimates of future revenue and expenses. There is inherent uncertainty in these estimates, and changes in these factors over time could result in an impairment charge.
 
A prolonged general economic downturn and, specifically, a prolonged downturn in the defense, communications or medical markets, or technological changes, as well as other market factors could intensify competitive pricing pressure, create an imbalance of industry supply and demand, or otherwise diminish volumes or profits. Such events, combined with changes in interest rates, could adversely affect our estimates of future net cash flows to be generated by our long-lived assets. Consequently, it is possible that our future operating results could be materially and adversely affected by additional impairment charges related to the recoverability of our long-lived assets.
 
Accounting for stock-based compensation
 
At the beginning of fiscal year 2006, we adopted SFAS No. 123 (revised 2004), "Share-Based Payment" ("SFAS No. 123R"), and Staff Accounting Bulletin (“SAB”) No. 107, "Share-Based Payment," for our existing stock option plans under the prospective method. Under the prospective method, only new awards (or awards modified, repurchased, or cancelled after the effective date) are accounted for under the provisions of SFAS No. 123R. Previously, we applied the intrinsic-value method of accounting prescribed by Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees," and related interpretations. Under the intrinsic-value method, compensation expense was recorded only if the market price of the stock exceeded the stock option exercise price at the measurement date. We will continue to account for stock option awards outstanding at September 30, 2005 on a graded vesting basis using the intrinsic-value method of measuring equity share options.
 
The fair value of each option award is estimated on the date of grant using the Black-Scholes model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable and requires the input of subjective assumptions, including the expected stock price volatility and estimated option life. For purposes of this valuation model, no dividends have been assumed.
 
In accordance with SFAS No. 123R, prior to becoming a public entity in April 2006, we used the minimum value method to determine a calculated value, rather than a fair value, of share awards. Under the minimum value method, stock price volatility was assumed to be zero. The estimated fair value (or calculated value, as applicable) of our stock-based awards, less expected forfeitures, is amortized over the awards' vesting period on a straight-line basis for awards granted after the adoption of SFAS No. 123R. Since our common stock has not been publicly traded for a sufficient time period, the expected volatility is based on expected volatilities of similar companies that have a longer history of being publicly traded. The risk-free rates are based on the U.S. Treasury yield in effect at the time of the grant. Since our historical data is limited, the expected life of options granted is based on the simplified method for plain vanilla options in accordance with SAB No. 107. In December 2007, the Securities and Exchange Commission issued SAB No. 110, an amendment of SAB No. 107. SAB No. 110 states that the staff will continue to accept, under certain circumstances, the continued use of the simplified method beyond December 31, 2007. Accordingly, we will continue to use the simplified method until we have enough historical experience to provide a reasonable estimate of expected term. For the three and six months ended March 28, 2008, we recognized $0.6 million and $1.0 million, respectively, in stock-based compensation expense. For the three and six months ended March 30, 2007, we recognized $0.3 million and $0.5 million, respectively, in stock-based compensation expense.
 
 
57

 
 
Income taxes
 
We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, tax benefits and deductions and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.
 
We must assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that all of the deferred tax assets recorded on our consolidated balance sheets will ultimately be recovered. However, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase in the period in which we determined that the recovery was not probable.
 
In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. In the first quarter of fiscal year 2008, we adopted FIN No. 48 and related guidance. See Note 9 to the consolidated condensed financial statements included in this Form 10-Q for further discussion. FIN No. 48 requires that we recognize liabilities for uncertain tax positions based on the two-step process prescribed within the interpretation. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible outcomes. We reevaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.
 
 
Item 3.        Quantitative and Qualitative Disclosures About Market Risk
 
We do not use market risk sensitive instruments for trading or speculative purposes.
 
Interest rate risk
 
Our exposure to market risk for changes in interest rates relates primarily to our long-term debt. As of March 28, 2008, we had fixed rate senior subordinated notes of $125.0 million due in 2012, bearing interest at 8% per year and variable rate debt consisting of $16.0 million floating rate senior notes due in 2015 and a $95.75 million term loan under our amended and restated senior credit facilities due in 2014. Our variable rate debt is subject to changes in the prime rate and the LIBOR rate.
 
We use derivative instruments from time to time in order to manage interest costs and risk associated with our long-term debt. On September 21, 2007, we entered into an interest rate swap contract to receive three-month USD-LIBOR-BBA interest and pay 4.77% fixed rate interest. Net interest positions are settled quarterly. We have structured the swap with decreasing notional amounts to match the expected pay down of the term loan. The notional value of the swap was $85.0 million at March 28, 
 
 
58

 
 
2008 and represented approximately 89% of the aggregate term loan balance. The swap agreement is effective through June 30, 2011. Under the provisions of SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities," as amended, this arrangement was initially designated and qualified as an effective cash flow hedge of interest rate risk related to the term loan under our senior credit facilities which permitted recording the fair value of the swap and corresponding unrealized gain or loss to accumulated other comprehensive income in the consolidated balance sheets. At March 28, 2008, the unrealized loss, net of tax, on the swap was $2.1 million.
 
We performed a sensitivity analysis to assess the potential loss in future earnings that a 10% increase in interest rates over a one-year period would have on our floating rate senior notes and term loan under our senior credit facilities. The impact was determined based on the hypothetical change from the end of period market rates over a period of one year and results in a net decrease of future annual earnings of approximately $0.1 million.
 
Foreign currency exchange risk
 
Although the majority of our revenue and expense activities are transacted in U.S. dollars, we do transact business in foreign countries. Our primary foreign currency cash flows are in Canada and several European countries. In an effort to reduce our foreign currency exposure to Canadian dollar denominated expenses, we enter into Canadian dollar forward contracts to hedge the Canadian dollar denominated costs for our manufacturing operation in Canada. Our Canadian dollar forward contracts are designated as a cash flow hedge and are considered highly effective, as defined by SFAS No. 133. The unrealized gains and losses from foreign exchange forward contracts are included in "accumulated other comprehensive income" in the consolidated balance sheets. If the transaction being hedged fails to occur, or if a portion of any derivative is ineffective, then we promptly recognize the gain or loss on the associated financial instrument in the consolidated statements of operations. No ineffective amounts were recognized due to anticipated transactions failing to occur in the three and six months ended March 28, 2008 and March 30. 2007.
 
As of March 28, 2008, we entered into Canadian dollar forward contracts for approximately $19.2 million (Canadian dollars), or approximately 70% of estimated Canadian dollar denominated expenses for April 2008 through September 2008, at an average rate of approximately $0.98 U.S. dollar to Canadian dollar. We estimate the impact of a 1 cent change in the U.S. dollar to Canadian dollar exchange rate (without giving effect to our Canadian dollar forward contracts) to be approximately $0.4 million annually to our net income or approximately 2.2 cents to basic earnings per share and 2.0 cents to diluted earnings per share.
 
Net income for the three and six months ended March 28, 2008 includes a recognized gain from foreign currency forward contracts of $0.4 million. Net income for the three and six months ended March 30, 2007 includes a recognized gain from foreign currency forward contracts of $0.1 million. At March 28, 2008 and September 28, 2007, the unrealized gain, net of tax, on Canadian dollar forward contracts was $5,000 and $1.2 million, respectively.
 
 
59

 

Item 4.        Controls and Procedures
 
Management, including our principal executive officer and principal financial officer, has evaluated, as of the end of the period covered by this report, the effectiveness of the design and operation of our disclosure controls and procedures with respect to the information generated for use in this report. Based upon, and as of the date of that evaluation, the principal executive officer and principal financial officer concluded that the disclosure controls and procedures were effective to provide reasonable assurances that information required to be disclosed in the reports filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
 
There have been no changes in our internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
60

 
 
Part II:  OTHER INFORMATION
 
Item 1.        Legal Proceedings
 
None.
 
 
Item 1A.     Risk Factors
 
For a discussion of risk factors, see "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended September 28, 2007. There have been no material changes from the risk factors disclosed in the "Risk Factors" section of our 2007 Form 10-K.
 
 
Item 2.        Unregistered Sales of Equity Securities and Use of Proceeds
 
None.
 
 
Item 3.        Defaults Upon Senior Securities
 
None.
 
 
Item 4.        Submission of Matters to a Vote of Security Holders
 
At an Annual Meeting of Stockholders held on February 26, 2008, the following proposals were presented for a vote of the stockholders of the Company:
 
Proposal No. 1: The election of the following two directors to serve for a three-year term ending at the 2011 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.
 
Nominee
 
For Votes
   
Withheld Votes
 
Michael Targoff
    14,002,823       1,958,641  
William P. Rutledge
    15,728,762       232,702  
 
The term of office for the following directors continued after the Annual Meeting: O. Joe Caldarelli, Michael F. Finley, Jeffrey Hughes and Stephen R. Larson.
 
Proposal No. 2: The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for fiscal year 2008.
 
Votes
 
Shares
 
For
    15,799,572  
Against
    101,592  
Abstain
    60,300  
 
 
 Item 5.       Other Information
 
None.
 
 
61

 
 
Item 6. Exhibits
 
No.
Description
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended.
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended.
32.1
Certifications of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certifications of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
62

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
                                  CPI INTERNATIONAL, INC.
 

 
Dated:  May 7, 2008
/s/ JOEL A. LITTMAN
 
Joel A. Littman
Chief Financial Officer, Treasurer and Secretary
(Duly Authorized Officer and Chief Financial Officer)

 
63